# EDGAR Filing Document

**Accession Number:** 0001015155
**File Stem:** 0001140361-25-028626
**Filing Date:** 2025-8
**Character Count:** 179937
**Document Hash:** 88fc5c8db66d4fea4031c697663acd9f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-028626.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0001140361-25-028626

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 72

**CONFORMED PERIOD OF REPORT**: 20250331

**FILED AS OF DATE**: 20250804

**DATE AS OF CHANGE**: 20250804

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CHARLES & COLVARD LTD
- **CENTRAL INDEX KEY:** 0001015155
- **STANDARD INDUSTRIAL CLASSIFICATION:** JEWELRY, SILVERWARE & PLATED WARE [3910]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 561928817
- **STATE OF INCORPORATION:** NC
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-23329
- **FILM NUMBER:** 251180936

**BUSINESS ADDRESS:**
- **STREET 1:** 170 SOUTHPORT DRIVE
- **CITY:** MORRISVILLE
- **STATE:** NC
- **ZIP:** 27560
- **BUSINESS PHONE:** 9194680399

**MAIL ADDRESS:**
- **STREET 1:** 170 SOUTHPORT DRIVE
- **CITY:** MORRISVILLE
- **STATE:** NC
- **ZIP:** 27560

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** C3 INC /NC/
- **DATE OF NAME CHANGE:** 19970829

?xml version='1.0' encoding='ASCII'?

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

#### FORM 10-Q

#### (Mark One)
☒ **Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

#### For the quarterly period ended March 31, 2025

#### OR
☐ **Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934**

#### For the transition period from ______ to ______

#### Commission File Number: 000-23329

#### Charles & Colvard, Ltd.
(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **North Carolina**<br>| **56-1928817**<br>|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

---

---

| | |
|:---|:---|
| **170 Southport Drive**<br>**Morrisville, North Carolina** | **27560**<br>|
| (Address of principal executive offices) | (Zip Code) |

---

(919) 468-0399

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, no par value per share<br>| CTHR<br>| OTC Experts Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 30, 2025, there were 3,118,273 shares of the registrant's common stock, no par value per share, outstanding.

------

#### EXPLANATORY NOTE
The following Quarterly Report on Form 10-Q (this "Form 10-Q") for Charles & Colvard, Ltd. (the "Company"), covers the three and nine months ended March 31, 2025, presents the Company and its results of operations for the periods indicated therein. Except as specifically designated therein, this Form 10-Q does not reflect events occurring after March 31, 2025, and the Company has not otherwise updated disclosures contained herein to reflect events that occurred at a later date.

------

#### CHARLES & COLVARD, LTD.

#### FORM 10-Q
For the Quarterly Period Ended March 31, 2025

#### **TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | Page<br> Number |
| **PART I – FINANCIAL INFORMATION** | **PART I – FINANCIAL INFORMATION** | **PART I – FINANCIAL INFORMATION** |
| Item 1. | Financial Statements |  |
|  | &nbsp;&nbsp;&nbsp; [Condensed Consolidated Balance Sheets as of March 31, 2025 (unaudited) and June 30, 2024](#BALANCESHEETS) | 1 |
|  | &nbsp;&nbsp;&nbsp; [Condensed Consolidated Statements of Operations (unaudited) for the three and nine months ended March 31, 2025 and 2024](#STATEMENTSOFOPERATIONS) | 2 |
|  | &nbsp;&nbsp;&nbsp; [Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited) for the three and nine months ended March 31, 2025 and 2024](#SHAREHOLDERSEQUITY) | 3 |
|  | &nbsp;&nbsp;&nbsp; [Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended March 31, 2025 and 2024](#CASHFLOWS) | 4 |
|  | [Notes to Condensed Consolidated Financial Statements (unaudited)](#NOTES) | 5 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#Item2.) | 19 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#Item3.) | 29 |
| Item 4. | [Controls and Procedures](#Item4.) | 29 |
| **PART II – OTHER INFORMATION** | **PART II – OTHER INFORMATION** | **PART II – OTHER INFORMATION** |
| Item 1. | [Legal Proceedings](#LegalProceedings) | 30 |
| Item 1A. | [Risk Factors](#RiskFactors) | 30 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#UnregisteredSalesofEquity) | 30 |
| Item 5.  | [Other Information ](#Item5.) | 30 |
| Item 6. | [Exhibits](#Item6.) | 31 |
|  | [Signatures](#SIGNATURES) | 32 |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### PART I – FINANCIAL INFORMATION
**Item 1.** **Financial Statements**<br>

#### CHARLES & COLVARD, LTD.

#### CONDENSED CONSOLIDATED BALANCE SHEETS

---

| | | |
|:---|:---|:---|
|  | **March 31, 2025**<br> (unaudited) | **June 30, 2024** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp; Cash and cash equivalents | $1257099 | $4137055 |
| &nbsp;&nbsp;&nbsp; Restricted cash | 447557 | 5328463 |
| &nbsp;&nbsp;&nbsp; Accounts receivable, net | 707427 | 844747 |
| &nbsp;&nbsp;&nbsp; Inventory, net | 5951565 | 7507303 |
| &nbsp;&nbsp;&nbsp; Note receivable | - | 250000 |
| &nbsp;&nbsp;&nbsp; Prepaid expenses and other assets | 678149 | 751476 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets | 9041797 | 18819044 |
| Long-term assets: |  |  |
| &nbsp;&nbsp;&nbsp; Inventory, net | 16013468 | 17423082 |
| &nbsp;&nbsp;&nbsp; Property and equipment, net | 2330618 | 2761618 |
| &nbsp;&nbsp;&nbsp; Intangible assets, net | 383406 | 370186 |
| &nbsp;&nbsp;&nbsp; Note receivable – long term | 250000 |  |
| &nbsp;&nbsp;&nbsp; Operating lease right-of-use assets | 1036480 | 1556653 |
| &nbsp;&nbsp;&nbsp; Other assets | 49658 | 49658 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total long-term assets | 20063630 | 22161197 |
| &nbsp;&nbsp;&nbsp; TOTAL ASSETS | $29105427 | $40980241 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp; Accounts payable | $6068683 | $8274284 |
| &nbsp;&nbsp;&nbsp; Short-term borrowings under line of credit<br>|  | 2300000 |
| &nbsp;&nbsp;&nbsp; Operating lease liabilities, current portion<br>| 922918 | 904330 |
| &nbsp;&nbsp;&nbsp; Accrued expenses and other liabilities | 2490351 | 2650532 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities | 9481952 | 14129146 |
| Long-term liabilities: |  |  |
| &nbsp;&nbsp;&nbsp; Noncurrent operating lease liabilities | 534923 | 1201722 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total long-term liabilities | 534923 | 1201722 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 10016875 | 15330868 |
| Commitments and contingencies (Note 9) |  |  |
| Shareholders' equity: |  |  |
| Common stock, no par value; 50,000,000 shares authorized; 3,157,114 shares issued and 3,118,273 shares outstanding at March 31, 2025 and 3,157,114 shares issued and 3,118,273 shares outstanding at June 30, 2024 | 67233259 | 67233259 |
| &nbsp;&nbsp;&nbsp; Additional paid-in capital | 16534984 | 16452615 |
| &nbsp;&nbsp;&nbsp; Treasury stock, at cost, 38,841 shares at both March 31, 2025 and June 30, 2024<br>| (489979) | (489979) |
| &nbsp;&nbsp;&nbsp; Accumulated deficit | (64189712) | (57546522) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total shareholders' equity | 19088552 | 25649373 |
| &nbsp;&nbsp;&nbsp; TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $29105427 | $40980241 |

---

See Notes to Condensed Consolidated Financial Statements (unaudited).

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### CHARLES & COLVARD, LTD.

#### CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine months Ended March 31,** | **Nine months Ended March 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net sales | $4049355 | $5261966 | $11912007 | $18120629 |
| Costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Cost of goods sold | 3118504 | 4076081 | 8475175 | 12134535 |
| &nbsp;&nbsp;&nbsp; Sales and marketing | 1524954 | 3684506 | 6174739 | 10702796 |
| &nbsp;&nbsp;&nbsp; General and administrative | 1374082 | 1199511 | 3907913 | 4550841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total costs and expenses | 6017540 | 8960098 | 18557827 | 27388172 |
| Loss from operations | (1968185) | (3698132) | (6645820) | (9267543) |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest income | 16136 | 74528 | 97881 | 244146 |
| &nbsp;&nbsp;&nbsp; Interest and other expense<br>| (21098) | (9103) | (95251) | (14672) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other income (expense), net | (4962) | 65425 | 2630 | 229474 |
| Loss before income taxes | (1973147) | (3632707) | (6643190) | (9038069) |
| Income tax expense<br>| - | - | - | - |
| Net loss<br>| $(1973147) | $(3632707) | $(6643190) | $(9038069) |
| Net loss per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic | $(0.63) | $(1.20) | $(2.13) | $(2.98) |
| &nbsp;&nbsp;&nbsp; Diluted | $(0.63) | $(1.20) | $(2.13) | $(2.98) |
| Weighted average number of shares used in computing net loss per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic | 3118273 | 3034495 | 3118273 | 3034495 |
| &nbsp;&nbsp;&nbsp; Diluted | 3118273 | 3034495 | 3118273 | 3034495 |

---

See Notes to Condensed Consolidated Financial Statements (unaudited).

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### CHARLES & COLVARD, LTD.

#### CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended March 31, 2025** | **Nine Months Ended March 31, 2025** | **Nine Months Ended March 31, 2025** | **Nine Months Ended March 31, 2025** | **Nine Months Ended March 31, 2025** | **Nine Months Ended March 31, 2025** |
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Number**<br> **of Shares** | **Amount** |<br>**Additional**<br> **Paid-in**<br> **Capital** |<br>**Treasury Stock**  |<br>**Accumulated**<br> **Deficit** |<br>**Total**<br> **Shareholders'**<br> **Equity** |
| Balance at June 30, 2024 | 3118273 | $67233259 | $16452615 | $(489979) | $(57546522) | $25649373 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation | - | - | 43422 |  | - | 43422 |
| &nbsp;&nbsp;&nbsp; Net loss<br>| - | - | - | - | (2133520) | (2133520) |
| Balance at September 30, 2024 | 3118273 | $67233259 | $16496037 | $(489979) | $(59680042) | $23559275 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation | - | - | 30981 |  | - | 30981 |
| &nbsp;&nbsp;&nbsp; Net loss | - | - | - | - | (2536523) | (2536523) |
| Balance at December 31, 2024 | 3118273 | 67233259 | $16527018 | $(489979) | $(62216565) | $21053733 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation<br>|  |  | 7966 |  |  | 7966 |
| &nbsp;&nbsp;&nbsp; Net loss<br>| - | - | - | - | (1973147) | (1973147) |
| Balance at March 31, 2025 | 3118273 | 67233259 | $16534984 | $(489979) | $(64189712) | $19088552 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended March 31, 2024** | **Nine Months Ended March 31, 2024** | **Nine Months Ended March 31, 2024** | **Nine Months Ended March 31, 2024** | **Nine Months Ended March 31, 2024** | **Nine Months Ended March 31, 2024** |
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Number**<br> **of Shares** | **Amount** |<br>**Additional** <br> **Paid-in**<br> **Capital** |<br>**Treasury Stock**  |<br>**Accumulated**<br> **Deficit** |<br>**Total**<br> **Shareholders'**<br> **Equity** |
| Balance at June 30, 2023 | 3052370 | $57242211 | $26205919 | $(489979) | $(43183565) | $39774586 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation | - | - | 51444 |  | - | 51444 |
| &nbsp;&nbsp;&nbsp; Net loss | - | - | - | - | (2539457) | (2539457) |
| Balance at September 30, 2023 | 3052370 | 57242211 | 26257363 | (489979) | (45723022) | 37286573 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation | - | - | 67174 |  | - | 67174 |
| &nbsp;&nbsp;&nbsp; Issuance of restricted stock<br>| (17875) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Net loss<br>| - | - | - | - | (2865905) | (2865905) |
| Balance at December 31, 2023 | 3034495 | 57242211 | 26324537 | (489979) | (48588927) | 34487842 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation  |  |  | 70344 |  |  | 70344 |
| &nbsp;&nbsp;&nbsp; Net loss<br>| - | - | - | - | (3632707) | (3632707) |
| Balance at March 31, 2024 | 3034495 | $57242211 | $26394881 | $(489979) | $(52221634) | $30925479 |

---

See Notes to Condensed Consolidated Financial Statements (unaudited).

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### CHARLES & COLVARD, LTD.

#### CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)

---

| | | |
|:---|:---|:---|
|  | **Nine months Ended March 31,** | **Nine months Ended March 31,** |
|  | **2025** | **2024** |
| CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
| Net loss<br>| $(6643190) | $(9038069) |
|  Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization | 651209 | 530161 |
| &nbsp;&nbsp;&nbsp; Stock-based compensation | 82369 | 188961 |
| &nbsp;&nbsp;&nbsp; Provision for uncollectible accounts | 85000 | 107000 |
| &nbsp;&nbsp;&nbsp; Recovery of sales returns | - | (160000) |
| &nbsp;&nbsp;&nbsp; Provision for accounts receivable discounts | - | 11976 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp; Accounts receivable | 52321 | (145461) |
| &nbsp;&nbsp;&nbsp; Inventory | 2965352 | 1445889 |
| &nbsp;&nbsp;&nbsp; Prepaid expenses and other assets<br>| 593500 | 574892 |
| &nbsp;&nbsp;&nbsp; Accounts payable | (2205602) | 1079280 |
| &nbsp;&nbsp;&nbsp; Accrued expenses and other liabilities | (808392) | (651388) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in operating activities | (5227433) | (6056759) |
| CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp; Purchases of property and equipment | (207754) | (723256) |
| &nbsp;&nbsp;&nbsp; Payments for intangible assets | (25675) | (49294) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in investing activities | (233429) | (772550) |
| CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from line of credit |  | 500000 |
| &nbsp;&nbsp;&nbsp; Repayment of the line of credit  | (2300000) |  |
| &nbsp;&nbsp;&nbsp; Net cash provided by (used in) financing activities <br>| (2300000) | 500000 |
|  NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | (7760862) | (6329309) |
|  CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD | 9465518 | 15568911 |
|  CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD | $1704656 | $9239602 |
|  Supplemental disclosure of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid during the period for income taxes | $- | $16486 |
| Cash paid during the period for interest expense<br>| $87372 | $10770 |

---

See Notes to Condensed Consolidated Financial Statements (unaudited).

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### CHARLES & COLVARD, LTD.

#### NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **DESCRIPTION OF BUSINESS** 

Charles & Colvard, Ltd. (the "Company"), a North Carolina corporation, was founded in 1995. The Company manufactures, markets, and distributes *Charles & Colvard Created Moissanite*<sup>®</sup> (hereinafter referred to as moissanite or moissanite jewels) and finished jewelry featuring moissanite, including *Forever One™*, the Company's premium moissanite gemstone brand, for sale in the worldwide fine jewelry market. The Company also markets and distributes *Caydia*<sup>®</sup> lab grown diamonds and finished jewelry featuring lab grown diamonds for sale in the worldwide fine jewelry market.

The Company sells loose moissanite jewels, loose lab grown diamonds, and finished jewelry featuring both moissanite and lab grown diamonds at wholesale prices to distributors, manufacturers, retailers, and designers, including some of the largest distributors and jewelry manufacturers in the world. In addition, in May 2023, the Company launched charlesandcolvarddirect.com, a direct-to-wholesaler sales portal, which is a gemstone product disposition wholesale outlet. The Company's finished jewelry and loose moissanite jewels and lab grown diamonds that are mounted into fine jewelry by other manufacturers are sold at retail outlets and via the Internet. The Company sells at retail prices to end-consumers through its own *Charles & Colvard Signature Showroom*, which opened in October 2022, and through its wholly-owned operating subsidiary, charlesandcolvard.com, LLC, third-party online marketplaces, drop-ship, and other pure-play, exclusively e-commerce outlets. The Company also sells at discount retail prices to end-consumers through moissaniteoutlet.com, LLC, a wholly-owned operating subsidiary of charlesandcolvard.com, LLC, and third-party online marketplaces.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES** 

***Basis of Presentation and Principles of Consolidation*** – The accompanying unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. However, certain information or footnote disclosures normally included in complete financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). In the opinion of the Company's management, the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q include all normal and recurring adjustments necessary for the fair statement of the results for the interim periods presented. The results for the three and nine months ended March 31, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2025.

The condensed consolidated financial statements as of March 31, 2025 and for the three and nine months ended March 31, 2025 and 2024 included in this Quarterly Report on Form 10-Q are unaudited. The balance sheet as of June 30, 2024 is derived from the audited financial statements as of that date. The accompanying statements should be read in conjunction with the audited financial statements and related notes contained in Item 8 of the Company's Annual Report on Form 10-K (the "2024 Annual Report") for the fiscal year ended June 30, 2024 or Fiscal 2024 filed with the SEC on April 3, 2025.

The accompanying condensed consolidated financial statements as of March 31, 2025 and June 30, 2024 and for the three and nine months ended March 31, 2025 and 2024, include the accounts of the Company and its wholly-owned subsidiaries charlesandcolvard.com, LLC, including its wholly-owned subsidiary, moissaniteoutlet.com, LLC, which was formed and incorporated as of February 24, 2022; Charles & Colvard Direct, LLC; and Charles & Colvard (HK) Ltd., the Company's Hong Kong subsidiary, which was entered into dormancy as of September 30, 2020 following its re-activation in December 2017. Charles & Colvard (HK) Ltd. previously became dormant in the second quarter of 2009 and has had no operating activity since 2008. Charles & Colvard Direct, LLC, had no operating activity during the three- and nine-month periods ended March 31, 2025 or 2024. All intercompany accounts have been eliminated.

***Going Concern*** – The Company's accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of obligations in the normal course of business. However, for the nine months ended March 31, 2025, the Company had losses of $6.64 million and cash flow used in operations of $5.23 million. These factors and the recent Wolfspeed arbitration award and related settlement agreement of $4.77 million raise substantial doubt about the Company's ability to continue as a going concern within one year from the date the financial statements are issued.

The Company's management is continuing to work on plans to fund operations to alleviate the conditions that raise substantial doubt by evaluating its financing arrangements, implementing cost savings actions to reduce cash outflow, and evaluating the liquidation of certain inventories, if needed. However, there can be no assurance that these plans will be successful or that additional financing will be available on terms acceptable to the Company.

------

[*Table of Contents*](#TABLEOFCONTENTS)

In view of these matters, continuation as a going concern is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to meet its financial requirements and the success of its future operations. The financial statements do not include any adjustments to the amount or the classification of assets and liabilities that may be necessary should the Company not continue as a going concern.

***Significant Accounting Policies*** – The Company's significant accounting policies used for the three and nine months ended March 31, 2025, are consistent with those used for the fiscal year ended June 30, 2024. Accordingly, please refer to Note 2 to the Consolidated Financial Statements in the 2024 Annual Report for the Company's significant accounting policies.

***Use of Estimates*** – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. As future events and their effects cannot be fully determined with precision, actual results of operations, cash flow, and financial position could differ significantly from estimates. The most significant estimates impacting the Company's condensed consolidated financial statements relate to the valuation and classification of inventories, accounts receivable reserves, stock-based compensation, valuation allowance for deferred income tax assets, and revenue recognition. Changes in estimates are reflected in the condensed consolidated financial statements in the period in which the change in estimate occurs.

***Restricted Cash*** – In accordance with the terms of the Company's cash collateralized $5.00 million credit facility from JPMorgan Chase Bank, N.A. ("JPMorgan Chase"), which the Company entered into on July 12, 2021, as amended July 28, 2022, June 21, 2023, July 29, 2024, amended further October 31, 2024, and expired on January 31, 2025, the Company was required to keep $5.1 million in a cash deposit account held by JPMorgan Chase. Such amount was held as security for the Company's credit facility from JPMorgan Chase. Accordingly, during the term of the JPMorgan Chase credit facility, the cash deposit held by JPMorgan Chase was classified as restricted cash for financial reporting purposes on the Company's Condensed Consolidated Balance Sheets.

For additional information regarding the Company's cash collateralized credit facility with JPMorgan Chase, see Note 10, "Debt".

In accordance with the terms of the Company's bank card/security agreement, entered into during the fiscal year ended June 30, 2024 with a third-party financial services company that offers business credit cards, the Company is required to keep cash in an account held by the third-party totaling $250,000. Such amount is held as security for the Company's bank card program with a credit limit of $500,000. Accordingly, this cash deposit held by the third-party financial service company is classified as restricted cash for financial reporting purposes on the Company's consolidated balance sheets.

The reconciliation of cash, cash equivalents, and restricted cash, as presented on the Condensed Consolidated Statements of Cash Flows, consist of the following as of the dates presented:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2025**  | **June 30,**<br> **2024** |
|  Cash and cash equivalents | $1257099 | $4137055 |
|  Restricted cash | 447557 | 5328463 |
| Total cash, cash equivalents, and restricted cash | $1704656 | $9465518 |

---

***Recently Adopted/Issued Accounting Pronouncements –*** In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "*Segment Reporting* (*Topic* 280): *Improvements to Reportable Segment Disclosures*" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant expenses. The updated standard is effective for annual periods beginning after December 15, 2024 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU.

In December 2023, the FASB issued ASU No. 2023-09 "*Income Taxes* (*Topic* 740): *Improvements to Income Tax Disclosures,*" which requires two primary disclosure enhancements: 1) disaggregated information on a reporting entity's effective tax rate reconciliation and 2) information on income taxes paid. For public business entities, the new requirements will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU.

In November 2024, the FASB issued ASU No. 2024-03 "*Income Statement—Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures*," which requires disaggregated disclosure of income statement expenses. For public business entities, the new requirements will be effective for annual periods beginning December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU.

------

[*Table of Contents*](#TABLEOFCONTENTS)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **SEGMENT INFORMATION AND GEOGRAPHIC DATA** 

The Company reports segment information based on the "management" approach. The management approach designates the internal reporting used by management for making operating decisions and assessing performance as the source of the Company's operating and reportable segments.

The Company manages its business through two operating and reportable segments based on its distribution channels to sell its product lines, loose jewels and finished jewelry: its "Online Channels" segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, charlesandcolvarddirect.com, madenetwork.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets; and its "Traditional" segment, which consists of wholesale and retail customers, including its own *Charles & Colvard Signature Showroom*. The accounting policies of the Online Channels segment and Traditional segment are the same as those described in Note 2, "Basis of Presentation and Significant Accounting Policies" and in the Notes to the Consolidated Financial Statements in the 2024 Annual Report.

The Company evaluates the financial performance of its segments based on net sales and product line gross profit, or the excess of product line sales over product line cost of goods sold. The Company's product line cost of goods sold is defined as product cost of goods sold and excludes certain indirect supporting expenses from the Company's manufacturing and production control departments, comprising personnel costs, and allocations for depreciation, leases, utilities, and corporate overhead; freight; inventory write-downs; and other inventory adjustments, comprising costs of quality issues, and damaged goods.

Summary financial information by reportable segment is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
|  | **Online**<br> **Channels** | **Traditional** | **Total** |
| Net sales |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $2376826 | $1552102 | $3928928 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 114084 | 6343 | 120427 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2490910 | $1558445 | $4049355 |
| Product line cost of goods sold |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $986979 | $1195555 | $2182534 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 44858 | 4211 | 49069 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $1031837 | $1199766 | $2231603 |
| Product line gross profit |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $1389847 | $356547 | $1746394 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 69226 | 2132 | 71358 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $1459073 | $358679 | $1817752 |
| Depreciation and amortization | $94189 | $122464 | $216653 |
| Capital expenditures | $41359 | $2475 | $43834 |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2024** | **Three Months Ended March 31, 2024** | **Three Months Ended March 31, 2024** |
|  | **Online**<br> **Channels** | **Traditional** | **Total** |
| Net sales |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $3840382 | $1044116 | $4884498 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 219828 | 157640 | 377468 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $4060210 | $1201756 | $5261966 |
| Product line cost of goods sold |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $1980096 | $737957 | $2718053 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 75243 | 76627 | 151870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2055339 | $814584 | $2869923 |
| Product line gross profit |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $1860286 | $306159 | $2166445 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 144585 | 81013 | 225598 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2004871 | $387172 | $2392043 |
| Depreciation and amortization | $41260 | $131882 | $173142 |
| Capital expenditures | $142756 | $85198 | $227954 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine months Ended March 31, 2025** | **Nine months Ended March 31, 2025** | **Nine months Ended March 31, 2025** |
|  | **Online**<br> **Channels** | **Traditional** | **Total** |
| Net sales |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $8228051 | $2934998 | $11163049 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 554702 | 194256 | 748958 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $8782753 | $3129254 | $11912007 |
| Product line cost of goods sold |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $4187357 | $2406033 | $6593390 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 248853 | 85352 | 334205 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $4436210 | $2491385 | $6927595 |
| Product line gross profit |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $4040694 | $528965 | $4569659 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 305849 | 108904 | 414753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $4346543 | $637869 | $4984412 |
| Depreciation and amortization | $281199 | $370010 | $651209 |
| Capital expenditures | $204454 | $3300 | $207754 |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine months Ended March 31, 2024** | **Nine months Ended March 31, 2024** | **Nine months Ended March 31, 2024** |
|  | **Online**<br> **Channels** | **Traditional** | **Total** |
| Net sales |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $13780906 | $2796204 | $16577110 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 850208 | 693311 | 1543519 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $14631114 | $3489515 | $18120629 |
| Product line cost of goods sold |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $6948411 | $1647325 | $8595736 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 271669 | 320569 | 592238 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $7220080 | $1967894 | $9187974 |
| Product line gross profit |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $6832495 | $1148879 | $7981374 |
| &nbsp;&nbsp;&nbsp; Loose jewels | 578539 | 372742 | 951281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $7411034 | $1521621 | $8932655 |
| Depreciation and amortization | $135411 | $394750 | $530161 |
| Capital expenditures | $442460 | $280796 | $723256 |

---

The Company does not allocate any assets to the reportable segments, and, therefore, no asset information is reported to the chief operating decision maker or disclosed in the financial information for each segment.

A reconciliation of the Company's product line cost of goods sold to cost of goods sold as reported in the condensed consolidated financial statements is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine months Ended March 31,** | **Nine months Ended March 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  Product line cost of goods sold | $2231603 | $2869923 | $6927595 | $9187974 |
|  Non-product line cost of goods sold: Manufacturing and production control expenses<br>| 401395 | 672373 | 1118772 | 1934837 |
|  Freight out | 108782 | 286526 | 392750 | 828990 |
|  Other inventory adjustments | 376724 | 247259 | 36058 | 182734 |
| &nbsp;&nbsp;&nbsp; Cost of goods sold | $3118504 | $4076081 | $8475175 | $12134535 |

---

A reconciliation of the Company's consolidated product line gross profit to the Company's consolidated net loss before income taxes is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine months Ended March 31,**  | **Nine months Ended March 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Product line gross profit | $1817752 | $2392043 | $4984412 | $8932655 |
| Non-allocated cost of goods sold | (886901) | (1206158) | (1547580) | (2946561) |
| Sales and marketing | (1524954) | (3684506) | (6174739) | (10702796) |
|  General and administrative | (1374082) | (1199511) | (3907913) | (4550841) |
| Other income (expense) net | (4962) | 65425 | 2630 | 229474 |
| &nbsp;&nbsp;&nbsp;&nbsp; Loss before income taxes | $(1973147) | $(3632707) | $(6643190) | $(9038069) |

---

The Company recognizes sales by geographic area based on the country in which the customer is based. Sales to international end consumers made through the Company's transactional websites, including charlesandcolvard.com, moissaniteoutlet.com, charlesandcolvarddirect.com and madeshopping.com, are included in international sales for financial reporting purposes. A portion of the Company's Traditional segment sales made to international wholesale distributors represents products sold internationally that may be re-imported to U.S. retailers.

------

[*Table of Contents*](#TABLEOFCONTENTS)

The following presents net sales data by geographic area:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine months Ended March 31,** | **Nine months Ended March 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net sales |  |  |  |  |
| &nbsp;&nbsp;&nbsp; United States | $4049355 | $5188939 | $11912007 | $17700626 |
| &nbsp;&nbsp;&nbsp; International | - | 73027 | - | 420003 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $4049355 | $5261966 | $11912007 | $18120629 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **FAIR VALUE MEASUREMENTS** 

Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability. The fair value hierarchy consists of three levels based on the reliability of inputs, as follows:

*Level 1.* Quoted prices in active markets for identical assets and liabilities;

*Level 2.* Inputs other than Level 1 quoted prices that are directly or indirectly observable; and

*Level 3.* Unobservable inputs that are not corroborated by market data.

The Company evaluates assets and liabilities subject to fair value measurements on a recurring and non-recurring basis to determine the appropriate level to classify them for each reporting period. This determination requires significant judgments to be made by the management of the Company. The financial instruments of the Company are cash and cash equivalents, restricted cash, notes receivable, trade accounts receivable, and trade accounts payable. All financial instruments are reflected in the condensed consolidated balance sheets at carrying value, which approximates fair value due to the short-term nature of these financial instruments.

The Company evaluated its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. The following tables summarize the Company's financial assets measured at fair value as of March 31, 2025 and June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fair value measurements on a recurring basis**<br> **March 31, 2025** | **Fair value measurements on a recurring basis**<br> **March 31, 2025** | **Fair value measurements on a recurring basis**<br> **March 31, 2025** | **Fair value measurements on a recurring basis**<br> **March 31, 2025** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Financial Assets:** | | | | |
| &nbsp;&nbsp;&nbsp; Money Market Fund (cash equivalents) | $22428 | $- | $- | $22428 |
| Total Financial Assets | $22428 | $- | $- | $22428 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fair value measurements on a recurring basis**<br> **June 30, 2024** | **Fair value measurements on a recurring basis**<br> **June 30, 2024** | **Fair value measurements on a recurring basis**<br> **June 30, 2024** | **Fair value measurements on a recurring basis**<br> **June 30, 2024** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Financial Assets:** | | | | |
| &nbsp;&nbsp;&nbsp; Money Market Fund (cash equivalents) | $773613 | $- | $- | $773613 |
| Total Financial Assets | $773613 | $- | $- | $773613 |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **INVENTORIES** 

The Company's total inventories, net, consisted of the following as of the dates presented:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2025** | **June 30,**<br> **2024** |
|  Finished jewelry: |  |  |
| &nbsp;&nbsp;&nbsp; Raw materials | $612011 | $1014072 |
| &nbsp;&nbsp;&nbsp; Work-in-process | 855736 | 433150 |
| &nbsp;&nbsp;&nbsp; Finished goods | 7862669 | 10927372 |
| &nbsp;&nbsp;&nbsp; Finished goods on consignment | 1845779 | 2247609 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total finished jewelry | $11176195 | $14622203 |
|  Loose jewels: |  |  |
| &nbsp;&nbsp;&nbsp; Raw materials | $1732876 | $1908677 |
| &nbsp;&nbsp;&nbsp; Work-in-process | 4518231 | 5393035 |
| &nbsp;&nbsp;&nbsp; Finished goods | 4172797 | 2577648 |
| &nbsp;&nbsp;&nbsp; Finished goods on consignment | 196936 | 201345 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total loose jewels | 10620840 | 10080705 |
|  Total supplies inventory | 167998 | 227477 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total inventory | $21965033 | $24930385 |

---

As of the dates presented, the Company's total inventories, net of reserves, are classified as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2025** | **June 30,**<br> **2024** |
|  Short-term portion | $5951565 | $7507303 |
|  Long-term portion | 16013468 | 17423082 |
| &nbsp;&nbsp;&nbsp; Total | $21965033 | $24930385 |

---

The Company's work-in-process inventories include raw SiC crystals on which processing costs, such as labor and sawing, have been incurred; and components, such as metal castings and finished goods set with moissanite jewels, that have been issued to jobs in the manufacture of finished jewelry. The Company's moissanite jewel manufacturing process involves the production of intermediary shapes, called "preforms," that vary depending upon the expected size and shape of the finished jewel. To maximize manufacturing efficiencies, preforms may be made in advance of current finished inventory needs but remain in work-in-process inventories. As of March 31, 2025 and June 30, 2024, work-in-process inventories issued to active production jobs approximated $996,000 and $841,000, respectively.

The Company's moissanite and lab grown diamond jewels do not degrade in quality over time and inventory generally consists of the shapes and sizes most commonly used in the jewelry industry. Product obsolescence is closely monitored and reviewed by management as of and for each financial reporting period.

The Company manufactures finished jewelry featuring moissanite, lab grown diamonds, and created color gemstones. Relative to loose moissanite jewels and lab grown diamonds, finished jewelry is more fashion-oriented and subject to styling trends that could render certain designs obsolete over time. The majority of the Company's finished jewelry featuring moissanite and lab grown diamonds is held in inventory for resale and largely consists of such core designs as stud earrings, solitaire and side-stone rings, pendants, and bracelets that tend not to be subject to significant obsolescence risk due to their classic styling. In addition, the Company generally holds smaller quantities of designer-inspired and trend fashion jewelry that is available for resale through retail companies and its Online Channels segment. The Company also carries inventory as part of its sample line that the Company uses in the selling process to its customers.

The Company's continuing operating subsidiaries carry no net inventories, and inventory is transferred without intercompany markup from the parent entity as product line cost of goods sold when sold to the end consumer.

The Company's inventories are stated at the lower of cost or net realizable value on an average cost basis. Each accounting period the Company evaluates the valuation and classification of inventories including the need for potential adjustments to inventory-related reserves, which include significant estimates by management, including the effect of market factors and sales trends. Changes to the Company's inventory reserves and allowances are accounted for in the accounting period in which a change in such reserves and allowances is observed and deemed appropriate, including changes in management's estimates used in the process to determine such reserves and valuation allowances.

------

[*Table of Contents*](#TABLEOFCONTENTS)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.** **NOTE RECEIVABLE** 

On March 5, 2021, the Company entered into a $250,000 convertible promissory note agreement (the "Convertible Promissory Note"), with an unrelated third-party strategic marketing partner. The Convertible Promissory Note is unsecured and was scheduled originally to mature on March 5, 2022. In February 2022, the Company entered into an amendment to the Convertible Promissory Note that was effective as of December 9, 2021 and changed the maturity date to September 30, 2022. Effective September 26, 2022, the Company further amended the Convertible Promissory Note (the "September 2022 Amendment") and changed the maturity date to June 20, 2024. Effective June 20, 2024, the Company further amended the Convertible Promissory Note (the "June 2024 Amendment") and changed the maturity date to March 31, 2025 (the "Maturity Date"). On March 28, 2025, the Maturity Date was extended (the "March 2025 Extension") to be the date that the unrelated third-party strategic marketing partner completes its next equity financing round of at least $25 million, which was expected to be in September 2025. On April 18, 2025, the unrelated third-party strategic marketing partner extended the next equity financing round from September 2025 to September 2026. In accordance with the terms of the March 2025 Extension and the revised timing of the equity financing round, the note receivable is classified as a non-current note receivable within the accompanying condensed consolidated financial statements as of March 31, 2025.

Interest is accrued at a simple rate of 0.14% per annum and will continue to accrue until the Convertible Promissory Note is converted in accordance with the conversion privileges contained within the Convertible Promissory Note or is repaid. Principal outstanding during an event of default accrues interest at the rate of 5% per annum.

Subject to the borrower's completion of a specified equity financing transaction (an "Equity Financing") on or prior to the Maturity Date, the unpaid principal amount, including accrued and unpaid interest, automatically converts into equity units of the most senior class of equity securities issued to investors in the Equity Financing at the lesser of 80% of the per unit price of the units purchased by investors or the price equal to $33,500,000 divided by the aggregate number of outstanding units of the borrower immediately prior to the closing of the financing. Unless converted as provided in the Convertible Promissory Note, the principal amount, including accrued and unpaid interest, will, on the Maturity Date, at the Company's option either (*i*) become due and payable to the Company, or (*ii*) convert into equity units at the specified conversion price in accordance with the terms of the Convertible Promissory Note. At the Maturity Date, if the Company does not convert the outstanding note into equity units and the borrower exercises their settlement option then the principal and accrued interest will be due upon the borrower completing another financing round of at least $25 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.** **ACCRUED EXPENSES AND OTHER LIABILITIES** 

Accrued expenses and other liabilities, current, consist of the following as of the dates presented:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2025** | **June 30,**<br> **2024** |
| Legal loss settlement | $1474567 | $1474567 |
| &nbsp;&nbsp;&nbsp; Deferred revenue  | 261961 | 301158 |
| Accrued compensation and related benefits  | 154117 | 145903 |
| &nbsp;&nbsp;&nbsp; Accrued sales taxes and franchise tax  | 182410 | 211337 |
|  Accrued cooperative advertising | 277274 | 415324 |
|  Other accrued expenses | 140022 | 102243 |
| Total accrued expenses and other liabilities | $2490351 | $2650532 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.** **INCOME TAXES** 

For the three and nine months ended March 31, 2025, the Company's statutory tax rate was 23.07% and consisted of the federal income tax rate of 21.00% and a blended state income tax rate of 2.07% net of the federal benefit. For both the three and nine months ended March 31, 2025, the Company's average effective tax rate was zero. For the three and nine months ended March 31, 2024, the Company's effective tax rate was 22.94% and consisted of the federal income tax rate of 21.00% and a blended state income tax rate of 1.94% net of the federal benefit. The Company's effective income tax rate reflects the effect of federal and state income taxes on earnings and the impact of differences in book and tax accounting arising primarily from the permanent tax benefits associated with stock-based compensation transactions during the accounting period then ended.

The Company recognized zero net income tax benefits for the three and nine months ended March 31, 2025 and 2024, respectively.

As of each reporting date, the Company's management considers new evidence, both positive and negative, that could impact its view with regard to future realization of deferred tax assets. As of March 31, 2025, the Company's management determined that sufficient negative evidence continued to exist to conclude it was uncertain that the Company would have sufficient future taxable income to utilize its deferred tax assets, and therefore, the Company maintained a full valuation allowance against its deferred tax assets.

------

[*Table of Contents*](#TABLEOFCONTENTS)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.** **COMMITMENTS AND CONTINGENCIES** 

#### Lease Arrangements
On December 9, 2013, the Company entered into a Lease Agreement, as amended on December 23, 2013, April 15, 2014, and January 29, 2021 (the "Lease Agreement"), for its corporate headquarters, which occupies approximately 36,350 square feet of office, storage and light manufacturing space and is classified as an operating lease for financial reporting purposes. The expiration date of the base term of the Lease Agreement, in effect as of March 31, 2025 is October 31, 2026, and the terms of the Lease Agreement contain no early termination provisions. Provided there is no outstanding uncured event of default under the Lease Agreement, the Company has an option to extend the lease term for a period of five years. The Company's option to extend the term of the Lease Agreement must be exercised in writing on or before 270 days prior to expiration of the then-current term. If the option is exercised, the monthly minimum rent for each of the extended terms will be adjusted to the then prevailing fair market rate.

The Company took possession of the leased property on May 23, 2014, once certain improvements to the leased space were completed and did not have access to the property before this date. Upon execution of the third amendment to the Lease Agreement (the "Lease Amendment") on January 29, 2021, the Lease Amendment included a rent abatement in the amount of approximately $214,000, which is reflected in the rent payments used in the calculation of the right-of-use ("ROU") asset and lease liability once remeasured upon the execution of the Lease Amendment to extend the lease term. The Lease Amendment also included an allowance for leasehold improvements offered by the landlord in an amount not to exceed approximately $545,000. As of the quarter ended March 31, 2025, the Company has been reimbursed approximately $545,000 by the landlord for qualified leasehold improvements in accordance with the terms of the Lease Amendment. This reimbursement by the landlord reduced the remaining ROU asset by the same amount and is being recognized prospectively over the remaining term of the lease.

The Company has no other material operating leases and is not party to leases that would qualify for classification as a finance lease, variable lease, or short-term lease.

As of March 31, 2025, the Company's balance sheet classifications of its leases are as follows:

---

| | |
|:---|:---|
| Operating Leases: |  |
| &nbsp;&nbsp;&nbsp; Noncurrent operating lease ROU assets | $1036480 |
| &nbsp;&nbsp;&nbsp; Current operating lease liabilities | $922918 |
| &nbsp;&nbsp;&nbsp; Noncurrent operating lease liabilities | 534923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total operating lease liabilities | $1457841 |

---

The Company's total operating lease cost for the three months ended March 31, 2025 and 2024 was approximately $205,000 and $175,000 respectively. The Company's total operating lease cost for the nine months ended March 31, 2025 and 2024 was approximately $634,000 and $524,000, respectively.

As of March 31, 2025, the Company's estimated incremental borrowing rate used and assumed discount rate with respect to operating leases was 2.81% and the remaining operating lease term was 1.58 years.

As of March 31, 2025, the Company's remaining future payments under operating leases for each fiscal year ending June 30 are as follows:

---

| | |
|:---|:---|
| 2025<br>| $231625 |
| 2026<br>| 943487 |
| 2027<br>| 317327 |
| Total lease payments | $1492439 |
| &nbsp;&nbsp;&nbsp; Less: imputed interest | (34598) |
| Present value of lease payments | 1457841 |
| &nbsp;&nbsp;&nbsp; Less: current lease obligations<br>| 922918 |
| Total long-term lease obligations<br>| $534923 |

---

The Company makes cash payments for amounts included in the measurement of its lease liabilities. During the three months ended March 31, 2025 and 2024 cash paid for operating leases was approximately $225,000 and $251,000, respectively. During the nine months ended March 31, 2025 and 2024, cash paid for operating leases was approximately $606,000 and $730,000, respectively.

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### Purchase Commitments
On December 12, 2014, the Company entered into an exclusive supply agreement (the "Supply Agreement") with Wolfspeed, Inc., formerly known as Cree, Inc. ("Wolfspeed"). Under the Supply Agreement, subject to certain terms and conditions, the Company agreed to exclusively purchase from Wolfspeed, and Wolfspeed agreed to exclusively supply, 100% of the Company's required SiC materials in quarterly installments that were required to equal or exceed a set minimum order quantity, contingent on the Company submitting purchase orders. The initial term of the Supply Agreement was scheduled to expire on June 24, 2018.

Effective June 22, 2018, the Company and Wolfspeed amended the Supply Agreement to extend the expiration date to June 25, 2023. This amendment also (i) provided the Company with one option, subject to certain conditions, to unilaterally extend the term of the Supply Agreement for an additional two-year period following expiration of the initial term; (ii) established a process by which Wolfspeed may begin producing alternate SiC material based on the Company's specifications that will give the Company the flexibility to use the materials in a broader variety of its products; and (iii) permitted the Company to purchase certain amounts of SiC materials from third parties under limited conditions.

Effective June 30, 2020, the Supply Agreement was further amended to extend the expiration date to June 29, 2025. This amendment also, among other things, (i) spread the Company's total purchase commitment, contingent on the Company submitting a purchase order, under the Supply Agreement in the amount of approximately $52.95 million over the term of the Supply Agreement, as amended; (ii) established a process by which Wolfspeed agreed to accept purchase orders in excess of the agreed-upon minimum purchase commitment, subject to certain conditions; and (iii) permitted the Company to purchase revised amounts of SiC materials from third parties under limited conditions.

During the nine months ended March 31, 2025 and 2024 the Company made no purchases of SiC crystals.

On July 28, 2023, Wolfspeed initiated a confidential arbitration against the Company for breach of contract claiming damages, plus interest, costs, and attorneys' fees. On February 10, 2025, the Company and Wolfspeed entered into a settlement agreement related to the Wolfspeed arbitration. Under the settlement agreement the Company terminated the Supply Agreement and agreed to pay Wolfspeed a total of $4.77 million, which included the purchased and consigned inventory, Wolfspeed's attorneys' fees in connection with the arbitration, and interest. As of March 31, 2025, the Company paid $2.33 million of the final settlement to Wolfspeed. The remaining settlement amount of $2.44 million will be paid on or before December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.** **DEBT** 

 ***#### Line of Credit
Effective July 7, 2021, the Company obtained from JPMorgan Chase a $5.00 million cash collateralized line of credit facility (the "JPMorgan Chase Credit Facility"). The JPMorgan Chase Credit Facility may be used for general corporate and working capital purposes, including permitted acquisitions and certain additional indebtedness for borrowed money, installment obligations, and obligations under capital and operating leases. The JPMorgan Chase Credit Facility is secured by a cash deposit in the amount of $5.1 million held by JPMorgan Chase as collateral for the line of credit facility and was scheduled to mature on July 31, 2022. Effective July 28, 2022, the JPMorgan Chase Credit Facility was amended to, among other things, extend the maturity date to July 31, 2023, and append the Company's obligations under the JPMorgan Chase Credit Facility to be guaranteed by the Company's wholly owned subsidiaries, Charles & Colvard Direct, LLC, charlesandcolvard.com, LLC, and moissaniteoutlet.com, LLC. Effective, June 21, 2023, the JPMorgan Chase Credit Facility was amended further to extend the maturity date to July 31, 2024. Effective July 29, 2024, the JPMorgan Chase Credit Facility was amended further to extend the maturity date to October 31, 2024, and effective October 31, 2024, the JPMorgan Chase Credit Facility was amended further to extend the maturity date to January 31, 2025.

Each advance under the JPMorgan Chase Credit Facility, as amended, accrues interest at a rate equal to the sum of JPMorgan Chase's monthly secured overnight financing rate ("SOFR rate") to which JPMorgan Chase is subject with respect to the adjusted SOFR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum and an unsecured to secured interest rate adjustment of 0.10% per annum. Prior to the July 31, 2022 amendment, each advance under the JPMorgan Chase Credit Facility would have accrued interest at a rate equal to JPMorgan Chase's monthly LIBOR rate multiplied by a statutory reserve rate for eurocurrency funding to which JPMorgan Chase is subject with respect to the adjusted LIBOR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum. Interest is calculated monthly on an actual/360-day basis and payable monthly in arrears. Principal outstanding during an event of default, at JPMorgan Chase's option, accrues interest at a rate of 3% per annum in excess of the above rate. Any advance may be prepaid in whole or in part without penalty at any time.

------

[*Table of Contents*](#TABLEOFCONTENTS)

The JPMorgan Chase Credit Facility is evidenced by a credit agreement, as amended, between JPMorgan Chase and the Company (the "JPMorgan Chase Credit Agreement"), effective as of June 21, 2023, and customary ancillary documents, in the principal amount not to exceed $5.00 million at any one time outstanding and a line of credit note (the "JPMorgan Chase Line of Credit Note") in which the Company promises to pay on or before July 31, 2024, the amount of $5.00 million or so much thereof as may be advanced and outstanding. In the event of default, JPMorgan Chase, at its option, may accelerate the maturity of advances outstanding under the JPMorgan Chase Credit Facility. The JPMorgan Chase Credit Agreement and ancillary documents contain customary covenants, representations, fees, debt, contingent obligations, liens, loans, leases, investments, mergers, acquisitions, divestitures, subsidiaries, affiliate transactions, changes in control, as well as indemnity, expense reimbursement, and confidentiality provisions.

In connection with the JPMorgan Chase Credit Facility, effective July 7, 2021, the Company incurred a non-refundable origination fee in the amount of $10,000 that was paid in full to JPMorgan Chase upon execution of the JPMorgan Chase Credit Facility on July 12, 2021. No origination fee was paid to JPMorgan Chase in connection with amending the JPMorgan Chase Credit Facility on July 28, 2022, June 21, 2023, July 29, 2024, and October 31, 2024. The Company also agreed to maintain its primary banking depository and disbursement relationship with JPMorgan Chase.

Events of default under the JPMorgan Chase Credit Facility include, without limitation, a default, event of default, or event that would constitute a default or event of default (pending giving notice or lapse of time or both), of any provision of the JPMorgan Chase Credit Agreement, the JPMorgan Chase Line of Credit Note, or any other instrument or document executed in connection with the JPMorgan Chase Credit Agreement or with any of the indebtedness, liabilities, and obligations of the Company to JPMorgan Chase or that would result from the extension of credit by JPMorgan Chase to the Company.

On January 31, 2025, the Company elected not to renew the cash collateralized $5.0 million line of credit facility with JP Morgan Chase Bank, N.A. As of March 31, 2025, the Company had repaid the $2.3 million balance related to the JPMorgan Chase Credit Facility and incurred approximately $95,000 of interest expense related to the JPMorgan Chase Credit Facility.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION** 

#### Common Stock
 ***The Company is authorized to issue 50,000,000 shares of common stock, no par value. As of March 31, 2025 and June 30, 2024, it had 3,118,273 shares of common stock outstanding for each period. Holders of the Company's common stock are entitled to one vote for each share held.***

#### Preferred Stock
 ***The Board of Directors is authorized, without further shareholder approval, to issue up to 10,000,000 shares of preferred stock, no par value. The preferred stock may be issued from time to time in one or more series. No shares of preferred stock had been issued as of March 31, 2025.***

#### Reverse Stock Split
***On May 14, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. Unless otherwise indicated, all share amounts, per share data, share prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted retroactively to reflect this reverse stock split.***

#### Repurchases of Common Stock
Pursuant to authority granted by the Company's Board of Directors on April 29, 2022, the Company could repurchase up to approximately $5.00 million in shares outstanding of the Company's common stock over the three-year period ending April 29, 2025. Pursuant to the terms of the repurchase authorization, the common stock share repurchases were generally at the discretion of the Company's management. As the Company repurchases its common shares, which have no par value, the Company reported such shares held as treasury stock in the accompanying condensed consolidated balance sheets with the purchase price recorded within treasury stock. The share repurchase agreement expired April 29, 2025.

During the nine-month periods ended March 31, 2025 and 2024 the Company repurchased no shares of its common stock.

#### Dividends
The Company has paid no cash dividends during the current fiscal year through March 31, 2025.

------

[*Table of Contents*](#TABLEOFCONTENTS)

***Stock-Based Compensation***

The following table summarizes the components of the Company's stock-based compensation included in net income for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** <br> **March 31,** | **Three Months Ended** <br> **March 31,** | **Nine months Ended** <br> **March 31**, | **Nine months Ended** <br> **March 31**, |
|  | **2025** | **2024** | **2025** | **2024** |
| Employee stock options | $7966 | $70343 | $82369 | $188961 |
| &nbsp;&nbsp;&nbsp; Totals | $7966 | $70343 | $82369 | $188961 |

---

No stock-based compensation was capitalized as a cost of inventory during the three and nine months ended March 31, 2025 or 2024.

*Stock Options –* The following is a summary of the stock option activity for the nine months ended March 31, 2025:

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Weighted**<br> **Average**<br> **Exercise Price** |
| Outstanding, June 30, 2024 | 268064 | $8.14 |
| &nbsp;&nbsp;&nbsp; Granted <br>| 2000 | $1.79 |
| &nbsp;&nbsp;&nbsp; Forfeited | (6778) | $5.77 |
| &nbsp;&nbsp;&nbsp; Expired | (33464) | $6.99 |
| Outstanding, March 31, 2025 | 229822 | $8.32 |

---

The weighted average grant date fair value of stock options granted during the nine months ended March 31, 2025 and 2024 was approximately $0.87 and $0.21, respectively. The total fair value of stock options that vested during the nine months ended March 31, 2025 and 2024 was approximately $199,385 and $224,000, respectively.

The following table summarizes information about stock options outstanding at March 31, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Options Outstanding** | **Options Outstanding** | **Options Outstanding** | **Options Exercisable** | **Options Exercisable** | **Options Exercisable** | **Options Vested or Expected to Vest** | **Options Vested or Expected to Vest** | **Options Vested or Expected to Vest** |
| Balance<br> as of<br> 03/31/2025 | Weighted<br> Average Remaining<br> Contractual Life<br> (Years) | Weighted<br> Average<br> Exercise<br> Price | Balance<br> as of<br> 03/31/2025 | Weighted<br> Average Remaining<br> Contractual Life<br> (Years) | Weighted<br> Average<br> Exercise<br> Price | Balance<br> as of<br> 03/31/2025 | Weighted<br> Average Remaining<br> Contractual Life<br> (Years) | Weighted<br> Average<br> Exercise<br> Price |
| 229822 | 6.19 | $8.32 | 217304 | 6.06 | $8.56 | 227605 | 6.17 | $8.37 |

---

As of March 31, 2025, the unrecognized stock-based compensation expense related to unvested stock options was approximately $23,024, which is expected to be recognized over a weighted average period of approximately 15 months.

The aggregate intrinsic value of stock options outstanding, exercisable, and vested or expected to vest at March 31, 2025 and 2024 was approximately $0 and $22,126 respectively. These amounts are before applicable income taxes and represent the closing market price of the Company's common stock at March 31, 2025, less the grant price, multiplied by the number of stock options that had a grant price that is less than the closing market price. These values represent the amount that would have been received by the optionees had these stock options been exercised on that date. There were no stock options exercised during the nine-month periods ended March 31, 2025 and 2024.

------

[*Table of Contents*](#TABLEOFCONTENTS)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12.** **NET LOSS PER COMMON SHARE** 

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods. Diluted net loss per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options and unvested restricted shares that are computed using the treasury stock method. Anti-dilutive stock awards consist of stock options that would have been anti-dilutive in the application of the treasury stock method.

The following table reconciles the differences between the basic and diluted net loss per share presentations:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended March 31** | **For the Three Months Ended March 31** | **For the Nine Months Ended March 31** | **For the Nine Months Ended March 31** |
|  | **2025** | **2024** | **2025**  | **2024** |
| Numerator |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Net loss | $(1973147) | $(3632707) | $(6643190) | $(9038069) |
|  Denominator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Weighted average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Basic | 3118273 | 3034495 | 3118273 | 3034495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effects of dilutive securities | - | - | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diluted | 3118273 | 3034495 | 3118273 | 3034495 |
| Net Loss per Common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic | $(0.63) | $(1.20) | (2.13) | $(2.98) |
| &nbsp;&nbsp;&nbsp; Diluted | $(0.63) | $(1.20) | (2.13) | $(2.98) |

---

For the three and nine months ended March 31, 2025, stock options to purchase approximately 230,000 shares were excluded from the computation of diluted net loss per common share because the effect of inclusion of such amounts would be anti-dilutive to net loss per common share.

For the three and nine months ended March 31, 2024, stock options to purchase approximately 275,000 shares were excluded from the computation of diluted net loss per common share because the effect of inclusion of such amounts would be anti-dilutive to net loss per common share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**13.** **MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK** 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash on deposit and cash equivalents held with banks and trade accounts receivable. The Company places cash deposits with federally insured financial institutions and maintains its cash at banks and financial institutions it considers to be of high credit quality. However, the Company's cash deposits may, at times, exceed the Federal Deposit Insurance Corporation's insurable limits. Accordingly, balances in excess of federally insured limitations may not be insured. The Company has not experienced losses on these accounts, and management believes that the Company is not exposed to significant risks on such accounts.

Trade receivables potentially subject the Company to credit risk. Payment terms on trade receivables for the Company's Traditional segment customers are generally between 30 and 90 days, though it may offer extended terms with specific customers and on significant orders from time to time. The Company extends credit to its customers based upon a number of factors, including an evaluation of the customer's financial condition and credit history that is verified through trade association reference services, the customer's payment history with the Company, the customer's reputation in the trade, and/or an evaluation of the Company's opportunity to introduce its moissanite jewels or finished jewelry featuring moissanite and lab grown diamonds to new or expanded markets. Collateral is not generally required from customers. The need for an allowance for uncollectible accounts is determined based upon factors surrounding the credit risk of specific customers, historical trends, and other information.

At times, a portion of the Company's accounts receivable will be due from customers that have individual balances of 10% or more of the Company's total gross accounts receivable.

------

[*Table of Contents*](#TABLEOFCONTENTS)

The following is a summary of customers that represent 10% or more of total gross accounts receivable as of the dates presented:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2025** | **June 30,**<br> **2024** |
| Customer A  | \*% | 19% |
| Customer B  | 30% | 15% |
| Customer C  | \*\* | 15% |
| Customer D | 17% | 12% |
|  Customer F  | 17% | \*\*\* |

---

\* Customer A did not have a balance that represented 10% or more of total gross accounts receivable as of March 31, 2025.

\*\* Customer C did not have a balance that represented 10% or more of total gross accounts receivable as of March 31, 2025.

\*\*\* Customer F did not have a balance that represented 10% or more of total gross accounts receivable as of June 30, 2024.

A significant portion of sales is derived from certain customer relationships. The following is a summary of customers that represent 10% or more of total net sales for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine months Ended March 31,** | **Nine months Ended March 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  Customer B (Online Channels/Traditional Segment)  | \*\*\*\* | 13% | 10% | 13% |
|  Customer E (Traditional Segment) | 17% | \*\*\*\*\* | 11% | \*\*\*\*\*\*\* |
|  Customer G (Traditional Segment) | 14% | \*\*\*\*\* | \*\*\*\*\*\* | \*\*\*\*\*\*\* |

---

---

| | |
|:---|:---|
| \*\*\*\* | Customer B did not have a balance that represented 10% or more of total net revenue for the three-month period ended March 31, 2025. |

---

---

| | |
|:---|:---|
| \*\*\*\*\* | Customers E and G did not have a balance that represented 10% or more of total net revenue for the three-month period ended March 31, 2024. |

---

---

| | |
|:---|:---|
| \*\*\*\*\*\* | Customer G did not have a balance that represented 10% or more of total net revenue for the nine-month period ended March 31, 2025. |

---

---

| | |
|:---|:---|
| \*\*\*\*\*\*\* | Customers E and G did not have a balance that represented 10% or more of total net revenue for the nine-month period ended March 31, 2024. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**14.** **SUBSEQUENT EVENTS** 

On June 24, 2025, the Company and Ethara Capital, LLC executed a Convertible Secured Note Purchase Agreement. Under the terms of the agreement, the Company will issue a $2 million secured convertible note to Ethara Capital, LLC and will accrue interest at a rate of 5% annually and is payable monthly. The convertible note matures three months after issuance. Ethara Capital, LLC has the option to extend the maturity of the secured convertible note up to 39 months after issuance. Subject to obtaining Company's shareholder approval, Ethara Capital, LLC, at its sole discretion can convert the outstanding principal balance and the unpaid interest into the Company's common stock.

------

[*Table of Contents*](#TABLEOFCONTENTS)

**Item 2.** **Management's Discussion and Analysis of Financial Condition and Results of Operations**<br>

*This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Statements expressing expectations regarding our future and projections relating to products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.*

*All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, the following:*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*1.* *The execution of our business plans could significantly impact our liquidity and there is substantial doubt about our ability to continue as a going concern;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*2.* *Our business and our results of operations could be materially adversely affected as a result of general economic and market conditions;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*3.* *Our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*4.* *We face intense competition in the worldwide gemstone and jewelry industry;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*5.* *We have historically been dependent on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*6.* *Constantly evolving privacy regulatory regimes are creating new legal compliance challenges;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*7.* *Our information technology, or IT, infrastructure, and our network has been and may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*8.* *We are subject to certain risks due to our international operations, distribution channels and vendors;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*9.* *Our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*10.* *We are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*11.* *We may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*12.* *Seasonality of our business may adversely affect our net sales and operating income;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*13.* *Our operations could be disrupted by natural disasters;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*14.* *Sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*15.* *Our current customers may potentially perceive us as a competitor in the finished jewelry business;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*16.* *If the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*17.* *Governmental regulation and oversight might adversely impact our operations;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*18.* *The effects of potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*19.* *We are subject to arbitration, litigation and demands, which could result in significant liability and costs, and impact our resources and reputation;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*20.* *The financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*21.* *Negative or inaccurate information on social media could adversely impact our brand and reputation;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*22.* *We rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*23.* *We may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*24.* *Environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*25.* *If we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*26.* *As a public reporting company, we are subject to rules and regulations established from time to time by the SEC regarding our internal control over financial reporting. If we fail to establish and maintain effective internal control over financial reporting and disclosure controls and procedures, we may not be able to accurately report our financial results, or report them in a timely manner;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*27.* *Our recent delisting from The Nasdaq Stock Market and move to over the counter ("OTC") trading could limit the liquidity and price of our common stock;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*28.* W *e could be negatively affected as a result of a proxy contest or other actions of activist shareholders;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*29.* *Some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company;* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*30.* *We cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term shareholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance, in addition to the other risks and uncertainties described in more detail in "Risk Factors" in Part I, Item 1A, of our 2024 Annual Report.* 

*Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission ("SEC") that discuss other factors relevant to our business.*

------

[*Table of Contents*](#TABLEOFCONTENTS)

The following discussion is designed to provide a better understanding of our unaudited condensed consolidated financial statements, including a brief discussion of our business and products, key factors that impacted our performance, and a summary of our operating results. This information should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and the consolidated financial statements and notes thereto and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, or the 2024 Annual Report. Historical results and percentage relationships related to any amounts in the condensed consolidated financial statements are not necessarily indicative of trends in operating results for future periods.

#### Overview

#### Our Mission
At Charles & Colvard, Ltd., our mission is to provide a more conscious and conflict-free fine jewelry experience for our customers. We are dedicated to blazing a more brilliant path forward with our *Made, not Mined*<sup>™</sup> gemstones and are committed to creating fine jewelry with a conscience.

#### About Charles & Colvard
Charles & Colvard, Ltd., a North Carolina corporation founded in 1995 (which may be referred to as Charles & Colvard, we, us, or our) is a globally recognized fine jewelry company specializing in lab created gemstones. We manufacture, market, and distribute *Charles & Colvard Created Moissanite*<sup>®</sup> (which we refer to as moissanite or moissanite jewels) since introducing created moissanite to the world three decades ago. After years of perfecting the process, Charles & Colvard debuted the world's first colorless moissanite and its premium moissanite gemstone brand, *Forever One*<sup>™</sup>, in 2015. As an e-commerce and multi-channel destination for fine jewelry featuring lab grown gemstones, we believe the addition of lab grown diamonds is a natural progression for the Charles & Colvard brand. In September 2020, we announced our expansion into the lab grown diamond market with the launch of *Caydia*<sup>®</sup>, our brand of premium lab grown diamonds.

We offer gemstones and finished jewelry featuring our proprietary moissanite jewels, premium lab grown diamonds, created color gemstones, and most recently, lab grown diamonds in color, for sale in the worldwide fine jewelry market through two operating segments: our Online Channels segment, which encompasses our digital properties components, comprised of our charlesandcolvard.com, moissaniteoutlet.com, charlesandcolvarddirect.com, and madenetwork.com websites, e-commerce outlets, including marketplaces, drop-ship customers, and other pure-play, exclusively e-commerce customers; and our Traditional segment, which consists of domestic and international distributors and retail customers, including end-consumers through our *Charles & Colvard Signature Showroom*, which opened in October 2022. We report segment information based on the "management" approach. This segment reporting approach designates the internal reporting used by management for making operating decisions and assessing performance as the source of our operating and reportable segments. We operate in an e-commerce environment characterized by both complexity in global markets and ongoing economic uncertainties in the U.S. and internationally. Our strategy is to build a globally revered and accessible brand of gemstones and finished fine jewelry products set with moissanite and lab grown diamonds. We believe our goods appeal to a broad consumer audience and leverage our advantage of being the original and leading worldwide source of moissanite and purveyor of premium lab grown diamonds. We believe a direct relationship with consumers is an essential component of this strategy, which entails delivering tailored educational content, engaging in an interactive dialogue with our audience, and positioning our brand to meet the demands of today's discerning consumer. A significant component of our strategy in this environment is to focus on our core products, improving the quality and predictability of the delivery of our products and services and placing those products quickly into the hands of our U.S. and international customers at affordable prices.

Moreover, recognizing today that our customers and vendors are resource-constrained, we are endeavoring to develop and extend our portfolio of products in a disciplined manner with a focus on domestic markets close to our core capabilities, and growing our global marketplace sales. We continue to focus on affordability initiatives. We also expect to continue innovating and investing in lab created gemstone technologies to fulfill evolving product requirements for our customers and investing in our people so that we have the technical and production skills necessary to succeed without limiting our ability to build sound financial returns to our investors.

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### Critical Accounting Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which we prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and related disclosures of contingent assets and liabilities. "Critical accounting estimates" are defined as those most important to the financial statement presentation and that require the most difficult, subjective, or complex judgments. We base our estimates on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Under different assumptions and/or conditions, those actual results of operations may materially differ. The most significant estimates impacting our consolidated financial statements relate to the valuation and classification of inventories, accounts receivable reserves, and revenue recognition. We also have other policies that we consider key accounting policies, but these policies typically do not require us to make estimates or judgments that are difficult or subjective.

We have disclosed our critical accounting estimates in our 2024 Annual Report, and that disclosure should be read in conjunction with this Quarterly Report on Form 10-Q. There have been no significant changes in our critical accounting estimates during the first nine months of Fiscal 2025.

#### Results of Operations
The following table sets forth certain consolidated statements of operations data for the three and nine months ended March 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Nine Months Ended March 31,** | **Nine Months Ended March 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  Net sales | $4049355 | $5261966 | $11912007 | $18120629 |
|  Costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Cost of goods sold | 3118504 | 4076081 | 8475175 | 12134535 |
| &nbsp;&nbsp;&nbsp; Sales and marketing | 1524954 | 3684506 | 6174739 | 10702796 |
| &nbsp;&nbsp;&nbsp; General and administrative | 1374082 | 1199511 | 3907913 | 4550841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total costs and expenses | 6017540 | 8960098 | 18557827 | 27388172 |
|  Loss from operations | (1968185) | (3698132) | (6645820) | (9267543) |
|  Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest income | 16136 | 74528 | 97881 | 244146 |
| &nbsp;&nbsp;&nbsp; Interest and other expense | (21098) | (9103) | (95251) | (14672) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other income (expense), net | (4962) | 65425 | 2630 | 229474 |
|  Loss before income taxes | (1973147) | (3632707) | (6643190) | (9038069) |
|  Income tax expense | - | - | - | - |
|  Net loss | $(1973147) | $(3632707) | $(6643190) | $(9038069) |

---

#### Consolidated Net Sales
Consolidated net sales for the three and nine months ended March 31, 2025 and 2024 comprise the following:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | **<br>Change** | **<br>Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | **Change** | **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  Finished jewelry | $3928928 | $4884498 | $(955570) | (20)% | 11163049 | 16577110 | $(5414061) | (33)% |
|  Loose jewels | 120427 | 377468 | (257041) | (68)% | 748958 | 1543519 | (794561) | (51)% |
| &nbsp;&nbsp;&nbsp; Total consolidated net sales | $4049355 | $5261966 | $(1212611) | (23)% | $11912007 | $18120629 | $(6208622) | (34)% |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

Consolidated net sales were $4.05 million for the three months ended March 31, 2025, compared to $5.26 million for the three months ended March 31, 2024, a decrease of approximately $1.21 million, or 23%. Consolidated net sales were $11.91 million for the nine months ended March 31, 2025, compared to $18.12 million for the nine months ended March 31, 2024, a decrease of approximately $6.21 million, or 34%. Overall, consumer confidence has continued to show signs of weakening due to general economic uncertainties, domestic and worldwide inflation, recessionary fears, and high interest rates. These same general economic conditions also caused weakness in demand for moissanite jewels from our domestic and international distributors, resulting in lower loose jewel and jewelry product net sales during the three and nine months ended March 31, 2025, in both of our operating segments.

Sales of finished jewelry represented 97% and 94% of total consolidated net sales for the three and nine months ended March 31, 2025, respectively, compared with 93% and 91%, respectively, of total consolidated net sales for the corresponding periods of the prior year. For the three months ended March 31, 2025, finished jewelry sales were $3.93 million compared to $4.88 million for the corresponding period of the prior year, a decrease of approximately $950,000 or 20%. For the nine months ended March 31, 2025, finished jewelry sales were $11.16 million compared to $16.58 million for the corresponding period of the prior fiscal year, a decrease of approximately $5.42 million, or 33%. These decreases in finished jewelry sales for the three and nine month periods ended March 31, 2025 were due primarily to lower demand across all of our finished jewelry products as a result of adverse global and domestic general economic conditions and increased competition.

Sales of loose jewels represented 3% and 6% of total consolidated net sales for the three and nine months ended March 31, 2025, respectively, compared to 7% and 9%, respectively, of total consolidated net sales for the corresponding periods of the prior year. For the three months ended March 31, 2025, loose jewel sales were $120,000 compared to $377,000 for the corresponding period of the prior year, a decrease of approximately $257,000, or 68%. For the nine months ended March 31, 2025, loose jewel sales were $749,000 compared to $1.54 million for the corresponding period of the prior fiscal year, a decrease of $795,000, or 51%. The decrease for the three and nine month periods ended March 31, 2025 was due primarily to lower sales of loose jewels through our distribution network in our Online Channels segment and Traditional segment as a result of global and domestic general adverse macroeconomic conditions and increased competition coupled with continued downward pricing pressure on mined and lab grown diamonds and in line with our strategic shift to a more direct-to-consumer business model.

U.S. net sales accounted for 100% of total consolidated net sales for each of the three and nine months ended March 31, 2025, compared with 99% and 98% for the three and nine months ended March 31, 2024. U.S. net sales decreased to $4.05 million, or 22%%, during the three months ended March 31, 2025 compared to $5.19 million in the comparable period of the prior fiscal year. U.S. net sales decreased to $11.91 million, or 33%, during the nine months ended March 31, 2025 from $17.70 million during the corresponding period of the prior year. U.S. net sales decreased during the three and nine months ended March 31, 2025 primarily due to decreased sales to U.S. customers in both our Online Channels segment and Traditional segment for the same reasons outlined above.

Our largest U.S. customer during the three and nine months ended March 31, 2025 accounted for 17% and 11% of total consolidated net sales during the periods. For the three month period ended March 31, 2025, we had one additional customer that accounted for 14% of total consolidated net sales. We had another customer that accounted for 10% of our net sales for the nine month period ended March 31, 2025.

Our largest U.S. customer during the three and nine months ended March 31, 2024 accounted for 13% of total consolidated net sales during each of the three and nine month periods ended March 31, 2024. We did not have another U.S. customer account for 10% or more of total consolidated sales during the three and nine months ended March 31, 2024. We expect that we and our customers will remain dependent on our ability to maintain and enhance our customer-related programs. A change in or loss of any of these customer or retailer relationships could have a material adverse effect on our results of operations.

International net sales accounted for 0% of total consolidated net sales for the three and nine month periods ended March 31, 2025, and 1% and 2% for the three and nine month periods ended March 31, 2024, respectively. International net sales decreased by $73,000 and $420,000 or 100% during the three and nine months ended March 31, 2025, compared to the respective periods in the prior year. International sales decreased due to lower demand in our international distributor market as a result of global general adverse macroeconomic conditions and increased competition coupled with continued downward pricing pressure on mined and lab grown diamonds. In light of the effects of ongoing global economic conditions, we continue to evaluate current and other potential distributors in international markets to determine the best long-term partners. As a result, and considering the ongoing international trade challenges, we expect that our sales in these markets may significantly fluctuate with each reporting period.

We did not have an international customer account for 10% or more of total consolidated sales during the three or nine months ended March 31, 2025 or 2024. A portion of our international consolidated sales represents jewels sold internationally that may be re-imported to U.S. retailers.

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### Costs and Expenses
*Cost of Goods Sold*

Our total cost of goods sold for the three and nine months ended March 31, 2025 and 2024 are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | **Change** | **Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | **Change** | **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  Product line cost of goods sold: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Finished jewelry | $2182534 | $2718053 | (535519) | (20)% | $6593390 | 8595736 | (2002346) | (23)% |
| &nbsp;&nbsp;&nbsp; Loose jewels | 49069 | 151870 | (102801) | (68)% | 334205 | 592238 | (258033) | (44)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total product line cost of goods sold | 2231603 | 2869923 | (638320) | (22)% | 6927595 | 9187974 | (2260379) | (25)% |
|  Non-product line cost of goods sold | 886901 | 1206158 | (319257) | (26)% | 1547580 | 2946561 | (1398981) | (47)% |
| &nbsp;&nbsp;&nbsp; Total cost of goods sold | $3118504 | $4076081 | (957577) | (23)% | $8475175 | 12134535 | (3659360) | (30)% |

---

Total cost of goods sold was $3.12 million for the three months ended March 31, 2025, compared to $4.08 million for the three months ended March 31, 2024, a decrease of approximately $960,000, or 23%. The total cost of goods sold was $8.48 million for the nine months ended March 31, 2025, compared to $12.13 million for the nine months ended March 31, 2024, a net decrease of approximately $3.66 million, or 30%. Product line cost of goods sold is defined as product cost of goods sold directly and excludes certain indirect supporting expenses from the manufacturing and production control departments, comprising personnel costs, allocations for depreciation, leases, utilities, and corporate overhead; freight; and period costs associated with other inventory adjustments, comprising costs of quality issues, and damaged goods.

The decrease in total cost of goods sold for the three months ended March 31, 2025, compared to the same period in 2024 was primarily due to decreased sales of loose jewels and finished jewelry during the three months ended March 31, 2025, in our Traditional and Online Channels as a result of lower product demand during the quarter, as well as a decrease in non-product line cost of goods sold.

The net decrease in non-product line cost of goods sold for the three months ended March 31, 2025, comprises: a $178,000 decrease in freight out principally from lower shipments during the period; and an approximate $271,000 decrease in non-capitalized manufacturing production control expenses principally related to the timing of when work-in-process goods are received into inventory and overhead costs are allocated. These decreases were partially offset by a $130,000 increase in other inventory adjustments principally related to changes in production standard cost variances.

The decrease in total cost of goods sold for the nine months ended March 31, 2025 compared to the same period in 2024 was also primarily driven by the decreased sales of finished goods and loose jewels during the nine months ended March 31, 2025 in both of our Online Channels segment and Traditional segment. We experienced lower demand in our Online Channels segment as a result of lower finished jewelry product demand during the nine month period despite the calendar year-end 2024 holiday season. We also and likewise saw lower loose jewel product demand in our Traditional segment throughout the nine month period.

The net decrease in non-product line cost of goods sold for the nine months ended March 31, 2025, comprises: a $816,000 decrease in indirect manufacturing production control expenses; a $436,240 decrease in freight out principally from decreased shipping volume; and a $147,000 decrease in other inventory adjustments principally related to production standard cost variances compared to those in the first nine months of 2024.

For additional disclosure relating to non-product line cost of goods sold, see Note 3 to our condensed consolidated financial statements in Item 1, "Financial Statements", of this Quarterly Report on Form 10-Q.

------

[*Table of Contents*](#TABLEOFCONTENTS)

*Sales and Marketing*

Sales and marketing expenses for the three and nine months ended March 31, 2025 and 2024 are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | **Change** | **Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | **Change** | **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  Sales and marketing | $1524954 | $3684506 | $(2159552) | (59)% | $6174739 | $10702796 | $(4528057) | (42)% |

---

Sales and marketing expenses were $1.52 million for the three months ended March 31, 2025 compared to $3.68 million for the three months ended March 31, 2024, a decrease of approximately $2.16 million, or 59%.

The decrease in sales and marketing expenses for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $1.52 million decrease in advertising and digital marketing expenses; a $278,000 decrease in compensation expense; a $257,000 decrease in professional services and marketing support; an $85,000 decrease in software-related costs incurred primarily in connection with software-related agreements; a $10,000 decrease in travel and entertainment; and a $9,000 decrease in general office-related expenses.

The decrease in advertising and digital marketing expenses for the three months ended March 31, 2025 compared to the same period in 2024 comprises: a $1.36 million decrease in online, television, and social media expenses; a $97,000 decrease in cooperative advertising expense related to consideration of these expenses as contra-revenue under ASC 606, and are reflected in that manner for Fiscal 2025; a $15,000 decrease in printed marketing and advertising costs; and a $48,000 decrease in advertising agency expenses.

The decrease in compensation expenses for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $254,000 decrease in salaries and related employee benefits, a $21,000 decrease in bonus expense, and a $2,000 decrease in share-based compensation expense.

The decrease in professional and marketing support expenses for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $213,000 decrease in marketing consulting expenses; and a $44,000 decrease in public relations expenses.

The decrease in sales and marketing expenses for the nine months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $3.13 million decrease in advertising and digital marketing expenses; a $603,000 decrease in compensation expense; a $203,000 decrease in general office-related expenses; a $612,000 decrease in professional services and marketing support; a $60,000 decrease in software-related expenses; a $29,000 decrease in travel and entertainment expense; a $19,000 decrease in telephone expense; and a $29,000 decrease in other miscellaneous expenses, mainly comprising recruiting fees. These decreases in sales and marketing expenses were partially offset by a $154,000 increase in depreciation and amortization expense.

The decrease in advertising and digital marketing expenses for the nine months ended March 31, 2025 compared to the same period in 2024 comprises: a $2.74 million decrease in online, television, and social media expenses; a $414,000 decrease in cooperative advertising expense related to consideration of these expenses as contra-revenue under ASC 606, and are reflected in that manner for Fiscal 2025; a $29,000 decrease in agency fees; and a $23,000 decrease in print media fees. These decreases were partially offset by: a $52,000 increase in promotional expense; and a $22,000 increase in trade show expenses.

The decrease in compensation expenses for the nine months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $588,000 decrease in salaries and related employee benefits, a $4,000 decrease in bonus expense; a $9,000 decrease in share-based compensation; and a $2,000 decrease in severance expense.

The decrease in general office-related expenses for the nine months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $175,000 decrease in bank fees; a $21,000 decrease in miscellaneous office related expenses; and a $7,000 increase insurance expenses.

The decrease in professional and marketing support expenses for the nine months ended March 31, 2025 compared to the same period in 2024 was primarily due: to a $370,000 decrease in marketing consulting expenses; and a $157,000 decrease in public and investor relations expenses.

------

[*Table of Contents*](#TABLEOFCONTENTS)

*General and Administrative*

General and administrative expenses for the three and nine months ended March 31, 2025 and 2024 are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | **Change** | **Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | **Change** | **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  General and administrative | $1374082 | $1199511 | $174571 | 15% | $3907913 | $4550841 | $(642928) | (14)% |

---

General and administrative expenses were $1.37 million for the three months ended March 31, 2025 compared to $1.20 million for the three months ended March 31, 2024, an increase of approximately $175,000, or 15%.

The increase in general and administrative expenses for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to a $502,000 increase in professional fees. This increase was partially offset by: a $170,000 decrease in compensation expense; a $65,000 decrease in travel and entertainment expense; a $47,000 decrease in board retainer fees; and a $45,000 decrease in general business taxes and licenses.

Professional services expenses increased for the three months ended March 31, 2025 compared to the same period in 2024 primarily due to: a net increase of $301,000 in corporate professional services, which the prior year included the reimbursement of certain professional fees by our insurance carrier totaling $232,000 related to the 2023 cybersecurity event; a $131,000 increase in contract labor; and a $71,000 increase in audit and tax related services.

The decrease in compensation expenses for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $111,000 decrease in salaries and benefits; a $50,000 decrease in share-based compensation; and a $9,000 decrease in bonus expense.

The decrease in general and administrative expenses for the nine months ended March 31, 2025 compared to the same period in 2024 was primarily due to: a $482,000 decrease in compensation expense; a $130,000 decrease in general business taxes and licenses; a $123,000 decrease in board retainer fees; a $64,000 decrease in insurance expense; a $57,000 decrease in travel and entertainment expense; a $22,000 decrease in bad debt expense; and a $73,000 decrease in other administrative expenses. These decreases were partially offset by: a $256,000 increase in professional service expense; and a $37,000 increase in bank fees.

Compensation expenses decreased for the nine months ended March 31, 2025, compared to the same period in 2024 principally due to: a $354,000 net decrease in salaries and related employee benefits; a $49,000 decrease in bonus expenses; and a $78,000 decrease in employee stock-based compensation expense.

Professional services fees increased for the nine months ended March 31, 2025, compared to the same period in 2024, primarily due to: a $319,000 increase in corporate professional consulting services, which the prior year included the reimbursement of certain professional fees by our insurance carrier totaling $232,000 related to the 2023 cybersecurity event; and a $165,000 increase in professional tax and audit services. These increases were partially offset by: a $150,000 decrease in legal fees; and $78,000 decrease in investor relations fees.

*Interest Income*

Interest income for the three and nine months ended March 31, 2025 and 2024 is as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | **Change** | **Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | **Change** | **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  Interest income | $16136 | $74528 | $(58392) | (78)% | $97881 | $244146 | $(146265) | (60)% |

---

Certain cash balances in excess of operating needs are deposited into and maintained in an interest-bearing account with a federally insured commercial bank. Accordingly, during the three and nine months ended March 31, 2025 and 2024, we earned interest from cash on deposit in this interest-bearing account. The decrease in earned interest for the three and nine month periods ended March 31, 2025 reflects a lower cash balance in interest bearing accounts and lower interest rates during the first three and nine month periods of Fiscal 2025 compared with Fiscal 2024.

------

[*Table of Contents*](#TABLEOFCONTENTS)

*Interest and Other Expense*

Interest and other expense for the three and nine months ended March 31, 2025 and 2024 is as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**<br> **March 31,** | **Three Months Ended**<br> **March 31,** | <br> **Change** | <br> **Change** | **Nine Months Ended**<br> **March 31,** | **Nine Months Ended**<br> **March 31,** | <br> **Change** | <br> **Change** |
|  | **2025** | **2024** | **Dollars** | **Percent** | **2025** | **2024** | **Dollars** | **Percent** |
|  Interest and other expense | $21098 | $9103 | $11995 | 132% | $95251 | $14672 | $80579 | 549% |

---

Interest and other expense incurred for the three and nine months ended March 31, 2025, was primarily a result of the drawdown on the Company's line of credit.

#### Provision for Income Taxes
For the three and nine months ended March 31, 2025, the Company's statutory tax rate was 23.07% and consisted of the federal income tax rate of 21.00% and a blended state income tax rate of 2.07%, net of the federal benefit. For both the three and nine months ended March 31, 2025, the Company's average effective tax rate was zero. For the three and nine months ended March 31, 2024 the Company's statutory tax rate was 22.94% and consisted of the federal income tax rate of 21.00% and a blended state income tax rate of 1.94%, net of the federal benefit. For the three and nine months ended March 31, 2024, the Company's effective tax rate was 0%. The Company's effective income tax rate reflects the effect of federal and state income taxes on earnings and the impact of differences in book and tax accounting arising primarily from the permanent tax benefits associated with stock-based compensation transactions during the accounting period then ended.

The Company recognized zero net income tax benefit for the three and nine months ended March 31, 2025 and 2024.

As of each reporting date, the Company's management considers new evidence, both positive and negative, that could impact its view with regard to future realization of deferred tax assets. As of March 31, 2025, the Company's management determined that sufficient negative evidence continued to exist to conclude it was uncertain that the Company would have sufficient future taxable income to utilize its deferred tax assets, and therefore, the Company maintained a full valuation allowance against its deferred tax assets.

#### Liquidity and Capital Resources

#### Liquidity and Capital Trends
We have concluded that our existing cash and cash equivalents and availability of other resources combined will not be sufficient to meet our working capital and capital expenditure needs over the next twelve months, and therefore, there is substantial doubt about the Company's ability to continue as a going concern within one year from the issuance of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. We are continuing to work on plans to fund operations and address the recent Wolfspeed arbitration award and settlement agreement to alleviate the conditions that raise substantial doubt by evaluating our financing arrangements, implementing cost savings actions to reduce cash outflow, and evaluating the liquidation of certain inventories, if needed. However, there can be no assurance that these plans will be successful or that additional financing will be available on terms acceptable to the Company. A more detailed description of our going concern is included in Note 2 to our condensed consolidated financial statements in Item 1, "Financial Statements", of this Quarterly Report on Form 10-Q.

#### Access to Capital Markets
Our access to the capital markets may be limited. Although we have an effective shelf registration statement on Form S-3 on file with the SEC that allows us to periodically offer and sell securities up to a total of $25.00 million, the shelf registration statement is currently not available to offer or sell shares of common stock due to the Company's late periodic filings, including this Form 10-Q. Additionally, even if we regain compliance with the SEC, we will only be able to raise one-third of our public float in the event that the aggregate market value of our outstanding common stock held by non-affiliates is less than $75 million over the sixty days prior to any offer or sale. As of July 30, 2025, our public float was approximately $800,000.

In addition to the foregoing, the Company's stock was delisted from the Nasdaq Stock Market on April 25, 2025 and is now traded on the OTC Expert Market.

------

[*Table of Contents*](#TABLEOFCONTENTS)

*Debt*

On June 24, 2025, the Company and Ethara Capital, LLC executed a Convertible Secured Note Purchase Agreement. Under the terms of the agreement, the Company will issue a $2 million secured convertible note to Ethara Capital, LLC and will accrue interest at a rate of 5% annually and is payable monthly. The convertible note matures three months after issuance. Ethara Capital, LLC has the option to extend the maturity of the secured convertible note up to 39 months after issuance. Subject to obtaining Company's shareholder approval, Ethara Capital, LLC, at its sole discretion can convert the outstanding principal balance and the unpaid interest into the Company's common stock.

#### Financing Activities
*Long-Term Financing Activities*

In accordance with authority granted by our Board of Directors on April 29, 2022, we could repurchase up to $5.00 million in shares outstanding of our common stock over the three-year period ending April 29, 2025. Pursuant to the terms of the repurchase authorization, the common stock share repurchases were generally at the discretion of management. As we repurchased our common shares, which have no par value, we reported such shares held as treasury stock on our condensed consolidated balance sheets, with the purchase price recorded within treasury stock. The Company's share repurchase program expired at the end of the term.

We repurchased no shares of our common stock during the three-month periods ended March 31, 2025 and 2024.

#### Operating Activities and Cash Flows
We require cash to fund our operating expenses and working capital requirements, including outlays for capital expenditures. As of March 31, 2025, our principal sources of liquidity were cash and cash equivalents totaling $1.26 million, trade accounts receivable of $707,000, and net current inventory of $5.95 million, as compared to cash and cash equivalents totaling $4.14 million, trade accounts receivable of $845,000, and net current inventory of $7.51 million as of June 30, 2024.

During the nine months ended March 31, 2025, our working capital decreased by approximately $5.13 million to $(440,000) from $4.69 million at June 30, 2024. As described more fully below, the decrease in working capital at March 31, 2025 is primarily attributable to: a net decrease in our cash, cash equivalents, and restricted cash; a decrease in our prepaid expenses and other assets; an increase in our accounts payable; and an increase in the current portion of our operating lease liabilities. These factors were offset partially by: an increase in our allocation of inventory from long-term to short-term due to a higher expected sell through of inventory on hand in the upcoming period; an increase in our accounts receivables; and a decrease in our accrued expenses and other liabilities. Our cash used for investing activities were principally used for the purchase of property and equipment.

During the nine months ended March 31, 2025, approximately $5.23 million of cash was used in our operations. The primary drivers of our use of cash were: a net loss in the amount of approximately $6.64 million; a $2.21 million decrease in accounts payables; and a decrease in accrued expenses and other liabilities of approximately $808,000. These factors were offset partially by: a decrease in inventory of approximately $2.97 million; a decrease in accounts receivable of approximately $52,000; non-cash expenditures of approximately $819,000; and a $594,000 decrease in prepaid expense and other assets.

From time to time, we have offered extended Traditional segment customer payment terms beyond 90 days to certain credit-worthy customers, the extension of which may not immediately increase liquidity as a result of ongoing current-period sales. In addition, we believe our competitors and other vendors in the wholesale jewelry industry have expanded their use of extended payment terms and, in aggregate, we believe that, through our use of extended payment terms, we provide a competitive response in our market during the current global economic environment. We believe that we are unable to estimate the impact of these actions on our net sales, but we believe that if we ceased providing extended payment terms, we would be at a competitive disadvantage for some Traditional segment customers in the marketplace during this economic period and our net sales and profits would likely be adversely impacted.

We manufactured approximately $578,000 and $1.09 million in loose jewels and $924,000 and $7.96 million in finished jewelry, which includes the cost of the loose jewels and the purchase of precious metals and labor in connection with jewelry production, during the nine months ended March 31, 2025 and 2024, respectively. We expect our purchases of precious metals and labor to fluctuate in conjunction with the levels of our finished jewelry business. In addition, the price of gold has fluctuated significantly over the past decade, resulting in higher retail price points for gold jewelry. Because the market prices of gold and other precious metals are beyond our control, upward price trends could have a negative impact on our operating cash flow as we manufacture finished jewelry.

------

[*Table of Contents*](#TABLEOFCONTENTS)

Historically, our raw material inventories of SiC crystals had been purchased under exclusive supply agreements with a limited number of suppliers. Because the supply agreements restricted the sale of these crystals exclusively to us, the suppliers negotiated minimum purchase commitments with us that, when combined with reduced sales levels during prior periods in which the purchase commitments were in effect, have resulted in levels of inventories that are higher than we might otherwise maintain. As of March 31, 2025 and June 30, 2024, $16.01 million and $17.42 million of our inventories were classified as long-term assets, respectively.

A more detailed description of our inventories is included in Note 5 to our condensed consolidated financial statements in Part I, Item 1, "Financial Statements", of this Quarterly Report on Form 10-Q.

As of March 31, 2025, all of our remaining federal income tax credits had expired or been utilized, and therefore, are not available to be carried forward to offset future income taxes. As of March 31, 2025, we also had federal tax net operating loss carryforwards of approximately $24.76 million expiring between 2034 and 2037, or that have no expiration, which can be used to offset against future federal taxable income; North Carolina tax net operating loss carryforwards of approximately $20.01 million expiring between 2023 and 2035; and various other state tax net operating loss carryforwards expiring between 2023 and 2040, which can be used to offset against future state taxable income.

#### Short-Term Capital Resources
*Line of Credit*

Effective July 7, 2021, we obtained from JPMorgan Chase our $5.00 million cash collateralized JPMorgan Chase Credit Facility. On January 31, 2025, we elected not to renew the JP Morgan Chase Credit Facility and as of March 31, 2025, the Company had repaid the $2.3 million balance related to the JPMorgan Chase Credit Facility.

*Convertible Secured Note*

On June 24, 2025, the Company and Ethara Capital, LLC executed a Convertible Secured Note Purchase Agreement. Under the terms of the agreement, the Company will issue a $2 million secured convertible note to Ethara Capital, LLC and will accrue interest at a rate of 5% annually and is payable monthly. The convertible note matures three months after issuance. Ethara Capital, LLC has the option to extend the maturity of the secured convertible note up to 39 months after issuance. Subject to obtaining Company's shareholder approval, Ethara Capital, LLC, at its sole discretion can convert the outstanding principal balance and the unpaid interest into the Company's common stock.

#### Long-Term Capital Commitments
*Contractual Agreement*

On December 12, 2014, the Company entered into an exclusive supply agreement (the "Supply Agreement") with Wolfspeed, Inc., formerly known as Cree, Inc. ("Wolfspeed"). Under the Supply Agreement, subject to certain terms and conditions, the Company agreed to exclusively purchase from Wolfspeed, and Wolfspeed agreed to exclusively supply, 100% of the Company's required SiC materials in quarterly installments that were required to equal or exceed a set minimum order quantity, contingent on the Company submitting purchase orders. The initial term of the Supply Agreement was scheduled to expire on June 24, 2018.

Effective June 22, 2018, the Company and Wolfspeed amended the Supply Agreement to extend the expiration date to June 25, 2023. This amendment also (*i*) provided the Company with one option, subject to certain conditions, to unilaterally extend the term of the Supply Agreement for an additional two-year period following expiration of the initial term; (*ii*) established a process by which Wolfspeed may begin producing alternate SiC material based on the Company's specifications that will give the Company the flexibility to use the materials in a broader variety of its products; and (*iii*) permitted the Company to purchase certain amounts of SiC materials from third parties under limited conditions.

Effective June 30, 2020, the Company and Wolfspeed further amended the Supply Agreement to extend the expiration date to June 29, 2025. This amendment also, among other things, (*i*) spread the Company's total purchase commitment, contingent on the Company submitting a purchase order, under the Supply Agreement in the amount of approximately $52.95 million over the term of the Supply Agreement, as amended; (*ii*) established a process by which Wolfspeed has agreed to accept purchase orders in excess of the agreed-upon minimum purchase commitment, subject to certain conditions; and (*iii*) permitted the Company to purchase revised amounts of SiC materials from third parties under limited conditions.

During the nine-months ended March 31, 2025 and 2024 the Company made no purchases of SiC crystals.

------

[*Table of Contents*](#TABLEOFCONTENTS)

On July 28, 2023, Wolfspeed initiated a confidential arbitration against the Company for breach of contract claiming damages, plus interest, costs, and attorneys' fees. On February 10, 2025, the Company and Wolfspeed entered into a settlement agreement related to the Wolfspeed arbitration. Under the settlement agreement the Company terminated the Supply Agreement and agreed to pay Wolfspeed a total of $4.77 million, which included the purchased and consigned inventory, Wolfspeed's attorneys' fees in connection with the arbitration, and interest. As of March 31, 2025, the Company paid $2.33 million of the final settlement to Wolfspeed. The remaining settlement amount of $2.44 million is to be paid on or before December 31, 2025.

For more information in connection with the Wolfspeed arbitration, see Part II, Item 2, "Legal Proceedings" and Note 9 to our condensed consolidated financial statements in Item 1, "Financial Statements", of this Quarterly Report on Form 10-Q.

**Item 3.** **Quantitative and Qualitative Disclosures About Market Risk**<br>

Not applicable.

**Item 4.** **Controls and Procedures**<br>

#### Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, our Chief Executive Officer and Executive Vice President and Chief Financial Officer concluded that, as of March 31, 2025, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting, described below.

#### Material Weaknesses in Internal Control over Financial Reporting
During the fiscal year ended June 30, 2024, management identified a material weakness related to the design and maintenance of information technology general controls ("ITGCs") related to user access and logical access, over the Company's key financial reporting systems.

During the fiscal year ended June 30, 2024, management also identified a deficiency constituting a material weakness related to the design and maintenance of effective controls for substantially all business processes. Specifically, management did not design certain review controls with sufficient precision to meet the control objective or retain sufficient evidence of the operation of controls.

The material weaknesses identified above did not result in any identified misstatements to our consolidated interim financial statements, and our management has concluded that the consolidated financial statements present fairly, in all material respects, our financial position, results of operations, and cash flows in conformity with U.S. GAAP.

#### Remediation Efforts
We have commenced measures to remediate the identified material weaknesses. Management has been and will continue designing and implementing an improved process for requesting, authorizing, and reviewing user access to key systems which impact our financial reporting, as well as enhancing the precision of management review controls. The material weaknesses will not be considered remediated until management designs and implements effective controls that operate for a sufficient period of time for management to conclude, through testing, that the controls are operating effectively. The identified material weaknesses are not considered remediated as of March 31, 2025 as remediation efforts are ongoing.

#### Changes in Internal Control Over Financial Reporting
Other than the remediation efforts described above, there were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### PART II – OTHER INFORMATION
**Item 1.** **Legal Proceedings**<br>

From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. The outcome of litigation is inherently uncertain, and there can be no assurances that favorable outcomes will be obtained. In addition, regardless of the outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors.

On July 28, 2023, Wolfspeed initiated a confidential arbitration against us for breach of contract claiming damages, plus interest, costs, and attorneys' fees. On February 10, 2025, the Company and Wolfspeed entered into a settlement agreement related to the Wolfspeed arbitration. Under the settlement agreement the Company terminated the Supply Agreement and agreed to pay Wolfspeed a total of $4.77 million, which includes the purchased and consigned inventory, Wolfspeed's attorneys' fees in connection with the arbitration, and interest. As of March 31, 2025, the Company paid $2.33 million of the final settlement to Wolfspeed. The remaining settlement amount of $2.44 million is to be paid on or before December 31, 2025.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

As of March 31, 2025, there were no material changes to the risks discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. There have been no material changes to such risks, other than as disclosed in this Quarterly Report on Form 10-Q.

**Item 2.** **Unregistered Sales of Equity Securities and Use of Proceeds**<br>

#### Issuer Purchases of Equity Securities

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total**<br> **Number**<br> **of Shares**<br> **Purchased** | **Average**<br> **Price Paid**<br> **per share** | **Total**<br> **Number of**<br> **shares Purchased**<br> **as Part of Publicly**<br> **Announced Plans**<br> **or Programs<sup>(1)</sup>** | **Approximate**<br> **Dollar Value of**<br> **Shares that May**<br> **Yet be Purchased**<br> **Under the Plans or**<br> **Programs** |
| January 1, 2025 – January 31, 2025 |  | $- |  | $4510021 |
| February 1, 2025 – February 29, 2025 |  | $- |  | $4510021 |
| March 1, 2025 – March 31, 2025 |  | $- |  | $4510021 |
| Total |  | $- |  | $4510021 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) On May 5, 2022, we announced that our Board of Directors had approved a share repurchase program to permit us to repurchase up to $5.00 million worth of our issued and outstanding common stock over the three year
 period ending April 29, 2025.

**Item 5.** **Other Information**<br>

During the three months ended March 31, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

[*Table of Contents*](#TABLEOFCONTENTS)

**Item 6.** **Exhibits**<br>

The following exhibits are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K:

---

| | |
|:---|:---|
| Exhibit No. | Description |
| [3.1](https://www.sec.gov/Archives/edgar/data/1015155/000119312505056618/dex31.htm) | Restated Articles of Incorporation of Charles & Colvard, Ltd. (incorporated herein by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended December 31, 2004). |
| [3.2](https://www.sec.gov/Archives/edgar/data/1015155/000110465924061659/tm2414501d1_ex3-1.htm) | Articles of Amendment to Restated Articles of Incorporation of Charles & Colvard, Ltd. (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K, as filed with the SEC on May 15, 2024). |
| [3.3](https://www.sec.gov/Archives/edgar/data/1015155/000101515511000022/exhibit31.htm) | Bylaws of Charles & Colvard, Ltd., as amended and restated, effective on May 19, 2011 (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, as filed with the SEC on May 24, 2011). |
| [3.4](https://www.sec.gov/Archives/edgar/data/1015155/000110465925006033/tm254282d1_ex3-1.htm) | Articles of Amendment to Bylaws of Charles & Colvard, Ltd., as amended and restated, effective May 19, 2011 (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, as filed with the SEC on January 24, 2025). |
| [10.1](ef20051325_ex10-1.htm) | Settlement Agreement, dated February 10, 2025 by and between Charles & Colvard Ltd. and Wolfspeed, Inc. |
| [10.2](https://www.sec.gov/Archives/edgar/data/1015155/000110465925026219/tm259890d1_ex10-1.htm) | Second Amendment to 2020 Amended and Restated Employment Agreement, dated March 18, 2025, by and between Charles & Colvard, Ltd. and Don O'Connell (incorporated herein by reference to Exhibit 10.1 to our Current Report on Form 8-K, as filed with the SEC on March 20, 2025). |
| [10.3](https://www.sec.gov/Archives/edgar/data/1015155/000110465924116481/tm2427918d1_ex10-1.htm) | Line of Credit Note, dated as of November 6, 2024 (effective October 31, 2024) by Charles & Colvard, Ltd. to JPMorgan Chase Bank (incorporated herein by reference Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on November 12, 2024). |
| [31.1](ef20051325_ex31-1.htm) | Certification by Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| [31.2](ef20051325_ex31-2.htm) | Certification by Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| [32.1](ef20051325_ex32-1.htm) | Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| [32.2](ef20051325_ex32-2.htm) | Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase document |
| 104 | Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101 |

---

------

[*Table of Contents*](#TABLEOFCONTENTS)

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | By: | **CHARLES & COLVARD, LTD.**<br>/s/ Don O'Connell |
| August 4, 2025 |  | Don O'Connell |
|  |  | President and Chief Executive Officer |
|  | By: | /s/ Clint J. Pete |
| August 4, 2025 |  | Clint J. Pete |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer and Chief Accounting Officer) |

---

------

## Exhibit 10.1

------

**Exhibit 10.1**<br>

**<u>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH "[\*\*\*]."</u>**

#### CONFIDENTIAL SETTLEMENT AGREEMENT
This Settlement Agreement ("Settlement Agreement"), is entered into by and between Wolfspeed, Inc. ("Wolfspeed") and Charles & Colvard, Ltd. ("C&C"). Wolfspeed and C&C are referred to collectively herein as the "Parties" and each a "Party".

#### RECITALS
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;&nbsp;&nbsp;&nbsp; On July 13, 2023, Wolfspeed filed an arbitration demand with the American Arbitration Association ("AAA") against C&C seeking damages for C&C's failure to purchase from Wolfspeed Silicon Carbide material that it had previously contracted to purchase under the parties' December 12, 2014, Exclusive Supply Agreement, as amended (the "Supply Agreement") An arbitration hearing was held in that matter from September 30 through October 2, 2024 (the "Arbitration").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On December 6, 2024, the arbitral panel issued an interim award finding that Wolfspeed was the prevailing party in the arbitration, and awarding Wolfspeed a sum of $3,296,974.28 in compensatory damages, prejudgment interest, and attorneys' fees and costs. The panel declined to include any [\*\*\*] in its interim award and instructed Wolfspeed not to include any attorneys' fees related to its alleged expectation damages or its expert witness fees and expenses in its petition for fees and costs. The panel further found C&C was obligated to pay all fees and expenses paid or due to the AAA related to the arbitration. In its order, the panel directed Wolfspeed to file a petition for its attorneys' fees and costs on or before January 6, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On December 11, 2024, C&C issued a press release and submitted a Form 8-K to the Securities and Exchange Commission, reporting the interim award (the "Disclosure").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On December 13, 2024, Wolfspeed sought a ruling from the panel as to whether the interim award was covered by the Parties' Stipulated Protective Order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On December 26, 2024, the arbitral panel ruled that the interim award was not covered by the Parties' Stipulated Protective Order, and to the extent the interim award is disseminated in the future, it is to be redacted in the manner set out by C&C. The panel further clarified that the applicable prejudgment interest rate is 12% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F.&nbsp;&nbsp;&nbsp;&nbsp; On January 6, 2025, Wolfspeed filed a fee petition seeking $611,305.78 in attorneys' fees and $102,042.65 in costs. Thereafter, C&C filed a responsive submission objecting to these amounts of fees and costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G.&nbsp;&nbsp;&nbsp;&nbsp; Wolfspeed contends, and C&C denies, that the interim award is covered by Paragraph 15(e) of the Supply Agreement, as well as the Parties' December 12, 2014, non- disclosure agreement.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H.&nbsp;&nbsp;&nbsp;&nbsp; The Parties desire to settle their dispute regarding the confidentiality of the interim award, the appropriate amount of attorneys' fees and costs, and to establish a mutually agreed structure and schedule for C&C's payment of sums awarded to Wolfspeed in this arbitration, through this Settlement Agreement pursuant to the express terms and conditions set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Parties desire to enter into this Settlement Agreement as a means of avoiding the costs of further litigation and of fully, fairly, and finally resolving existing or potential disputes between the Parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;J.&nbsp;&nbsp;&nbsp;&nbsp; The Parties acknowledge and agree that each Party is receiving reasonably equivalent value in exchange for and has received substantial new value for entering into this Settlement Agreement and performing their respective obligations contemplated hereunder, and the transfers contemplated herein are made to be a contemporaneous exchange for new value.

NOW, THEREFORE, in consideration of the mutual undertakings set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the Parties agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **<u>Incorporation of Recitals</u>**. Each of the recitals set forth above is fully incorporated into and made a part of this Settlement Agreement. Without limitation, each Party hereby acknowledges and agrees that such recitals are true and correct and form the basis for, and are a material part of, this Settlement Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **<u>Consideration</u>**. The Parties acknowledge that each of them is providing and receiving valuable consideration in the form of the mutual covenants and agreements set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **<u>Parties' Obligations; Covenants</u>**. As obligations under this Settlement Agreement, the Parties agree that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As soon as practicable, but, in any event no later than one day after the Effective Date of this Settlement Agreement, C&C shall pay to Wolfspeed $500,000.00 via wire transfer using the instructions attached as Exhibit 1.

(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No later than February 28, 2025, C&C shall pay to Wolfspeed $1,834,105.

(c) On or before December 31, 2025, C&C shall pay to Wolfspeed $2,437,095.89 (the "Final Settlement Payment"). The Final Settlement Payment shall be made using the same wire instructions included in paragraph 3(a), unless Wolfspeed or its counsel provides alternative wire instructions to C&C in advance of the payment

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C&C will be solely responsible for and will arrange to promptly pay in full all invoices that the AAA has issued or may in the future issue to C&C or Wolfspeed for costs of the Arbitration;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u> </u><u>Confidentiality</u>. The Parties mutually agree not to disclose, and to protect against and prevent disclosure of, the arbitral panel's interim award or any final award in this matter, provided however, that nothing in this provision shall prevent a Party from making any disclosures that may be required by applicable securities regulations or law or applicable listing standards, or from communicating the terms of the interim or final award to their legal counsel, tax advisors, and accountants. Further, this confidentiality provision does not prevent either Party from disclosing any information about the interim award that is already public, including any information included in the Disclosure other than the prejudgment interest rate set forth in the Disclosure, which the Parties agree and acknowledge has been amended to 12%. C&C further agrees to disclose to Wolfspeed any draft press release it intends to make related to the interim or final award or the Arbitration. The Parties agree that any violation of this confidentiality provision shall result in the violating Party paying liquidated damages to the other Party in the amount of $100,000.00 per violation. The Parties agree and acknowledge that they have existing non-disclosure and confidentiality obligations to one another, which are not affected by this agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Lien on C&C's Assets</u>. In order to provide Wolfspeed appropriate security for the payment of the Final Settlement Payment, C&C agrees to grant Wolfspeed a lien on C&C's assets for the full amount of the Final Settlement Payment. Promptly, but in any event within two (2) business days of full payment by C&C of the Final Settlement Payment, Wolfspeed shall release any lien rights conferred herein or otherwise held by Wolfspeed and file a UCC-3 termination statement with the North Carolina Secretary of State, terminating any UCC-1 Wolfspeed holds with respect to C&C's assets. Notwithstanding the foregoing, Wolfspeed shall not unreasonably refuse to execute, or cause to be executed, a subordination agreement and any other documents or agreements reasonably requested by C&C's or any of C&C's affiliates' lenders (other than a mezzanine lender) from time to time with respect to the payment of the Final Settlement Payment and any lien held by Wolfspeed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Covenant Not to Sue</u>. Except for actions to enforce the terms of this Settlement Agreement, the Parties covenant and agree not to bring any claims against each other or the other Released Parties (as defined herein) regarding the matters settled, released and dismissed herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp; <u>Final Award</u>. The Parties will jointly inform the AAA Panel in writing that they will consent to entry of a Final Award in substantially the same form as the interim award, but reflecting a prejudgment interest rate of 12% and noting that the parties have executed this Settlement Agreement to address the payment of attorneys' fees, ongoing confidentiality, and timing of payments from C&C to Wolfspeed. The Parties will jointly cooperate with the AAA to finalize the award and close the file. For the avoidance of doubt, C&C's payment obligation to Wolfspeed arises solely out of this Settlement Agreement, rather than any award entered by the arbitral panel.

------

4.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Releases</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp; C&C, on behalf of itself and its current, former and future members, agents, representatives, assigns, employees, managers, officers, directors, affiliates, subsidiaries, partners, predecessors, and successors hereby forever releases and discharges Wolfspeed and Wolfspeed's respective current, former and future members, agents, representatives, assigns, employees, managers, officers, directors, affiliates, subsidiaries, shareholders, partners, investors, predecessors, and successors (collectively, the "Wolfspeed Released Parties") from any and all pending and potential claims, counterclaims, crossclaims, demands, actions, causes of action, damages, obligations, suits or proceedings, rights, defenses, affirmative defenses, losses, costs, attorneys' fees, expenses and all liabilities and compensation of any nature whatsoever and of any kind or character, whether known, unknown, suspected, unsuspected, fixed, contingent, liquidated, unliquidated, matured, unmatured, disputed, undisputed, legal, equitable, secured, or unsecured, arising out of or related to the Arbitration between the Parties, the Supply Agreement, or the Disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp; Wolfspeed, on behalf of itself and its current, former and future members, agents, representatives, assigns, employees, managers, officers, directors, affiliates, subsidiaries, partners, predecessors, and successors hereby forever releases and discharges C&C and C&C's respective current, former and future members, agents, representatives, assigns, employees, managers, officers, directors, affiliates, subsidiaries, shareholders, partners, investors, predecessors, and successors (collectively, the "C&C Released Parties") (Together the Wolfspeed Released Parties and the C&C Released Parties are the "<u>Released Parties</u>") from any and all pending and potential claims, counterclaims, crossclaims, demands, actions, causes of action, damages, obligations, suits or proceedings, rights, defenses, affirmative defenses, losses, costs, attorneys' fees, expenses and all liabilities and compensation of any nature whatsoever and of any kind or character, whether known, unknown, suspected, unsuspected, fixed, contingent, liquidated, unliquidated, matured, unmatured, disputed, undisputed, legal, equitable, secured, or unsecured, arising out of or related to the Arbitration between the Parties, the Supply Agreement, or the Disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **<u>Conditions Precedent</u>**. This Settlement Agreement shall become effective and binding upon the Parties as of the date above first written when all of the following events and conditions shall have occurred (the "<u>Effective Date</u>"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; each Party shall have fully executed, delivered and released its signature page to this Settlement Agreement to the other Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **<u>Notice</u>**. Any notice or request hereunder shall be given only by, and shall be deemed to have been received upon: (i) registered or certified mail, return receipt requested, on the date on which such mail is received as indicated in such return receipt or (ii) delivery by a nationally recognized overnight courier, one (1) business day after deposit with such courier. Any notice or request under this Settlement Agreement shall be given to any Party to this Settlement Agreement at such Party's address set forth below, or at such other address as such party may hereafter specify in a notice given in the manner required under this <u>Section 6</u>:

------

If to Wolfspeed:

Melissa Garrett, General Counsel

4600 Silicon Drive

Durham, NC 27703

Melissa.garrett@wolfspeed.com

with a copy to

Katten Muchin Rosenman LLP

Attn: Rebecca K. Lindahl

615 S. College Street, Suite 1700

Charlotte, NC 28202

rebecca.lindahl@katten,com

If to C&C:

Charles & Colvard, Ltd.

170 Southport Drive

Morrisville, North Carolina 27560

Attn: Legal

Email: legal@charlesandcolvard.com<br>

with a copy to:

Wyrick Robbins Yates & Ponton, LLP

Samuel A. Slater, Esq.

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

Email: sslater@wyrick.com

7. **<u>Miscellaneous</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Confidentiality of Settlement Agreement</u>. The terms and conditions of this Settlement Agreement are confidential between the Parties and shall not be disclosed to any other party except as may be necessary to effectuate its terms, provided however, that nothing in this provision shall prevent a Party from making any disclosures that may be required by applicable securities regulations or law or applicable listing standards. Further this provision shall not prevent a Party from communicating the terms of the Settlement Agreement to its legal counsel, tax advisors, accountants, and consultants in connection with the performance of services for such Party, or to a Party's lenders, affiliates' lenders, and prospective strategic partners, in connection with due diligence activities, provided that such Party first advises such persons of the confidentiality provisions of this Settlement Agreement and secures those persons' agreement not to communicate, discuss, disclose, or publish the terms and conditions of this Settlement Agreement.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp; <u>The Supply Agreement</u>. For the avoidance of doubt, the Parties acknowledge that the Supply Agreement is no longer in force or effect and that neither Party has any obligation to the other under the Supply Agreement, other than any obligation, which by the Supply Agreement's express terms, survives the termination or expiration thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Governing Law/Choice of Venue/Consent to Jurisdiction/Waiver of Jury</u> <u>Trial</u>. This Settlement Agreement shall be governed and controlled as to validity, enforcement, interpretation, construction, effect and in all other respects by the internal laws of the State of North Carolina, without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other than those of the State of North Carolina. Each Party agrees to the exclusive jurisdiction of the AAA with respect to any claim or cause of action arising under or relating to this Settlement Agreement. Each party waives any objection based on *forum non conveniens* and waives any objection to venue of any action instituted hereunder. EACH PARTY HERETO IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, PROCEEDING, OR COUNTERCLAIM OF ANY KIND ARISING OUT OF OR RELATED TO THIS SETTLEMENT AGREEMENT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp; <u>Severability; Counterparts; Facsimile Signatures</u>. If any provision of this Settlement Agreement is adjudicated to be invalid under applicable laws or regulations, such provision shall be inapplicable to the extent of such invalidity without affecting the validity or enforceability of the remainder of this Settlement Agreement which shall be given effect so far as possible. This Settlement Agreement may be executed in one or more counterparts, all of which taken together shall constitute but one and the same instrument. Delivery of an executed counterpart of this Settlement Agreement by facsimile transmission or e-mail (in .pdf or similar format) shall be as effective as delivery of a manually executed counterpart hereof, shall be treated as an original signature for all purposes of this Settlement Agreement and shall be fully effective to bind such party to the terms of this Settlement Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Further Assurances</u>. Each Party covenants and agrees that it will at any time and from time to time do, execute, acknowledge and deliver, or will cause to be done, executed, acknowledged and delivered, all such further acts, documents and instruments as reasonably may be required to effectuate fully the intent of this Settlement Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Successors and Assigns; No Third Party Beneficiaries</u>. This Settlement Agreement shall be binding upon all Parties to this Settlement Agreement, and their heirs, administrators, representatives, executors, successors, and assigns, and shall inure to the benefit of all Parties to this Settlement Agreement, and to their successors and assigns. The Parties may not assign, delegate or transfer this Settlement Agreement or any of the rights or obligations under this Settlement Agreement unless by the Parties' written consent; provided however, that either party may assign this Settlement Agreement without the other's consent in the case of a reorganization, merger, consolidation, or sale of all or substantially all of its assets. No rights are intended to be created under this Settlement Agreement for the benefit of any third party donee, creditor or incidental beneficiary of any Party.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Authority to Settle and Compromise Claims</u>. The Parties represent and warrant to each other that: (a) they have the legal capacity and authority to enter into this Settlement Agreement and authorized signatories have signed this Settlement Agreement on their behalf, and (b) this Settlement Agreement constitutes the voluntary, legal, valid and binding obligation of said Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>No Admission of Liability</u>. The Parties acknowledge, covenant and agree that this Settlement Agreement is the result of a compromise and shall never at any time for any purpose be construed as an admission by the Parties of any liability or responsibility to any other Party, or to any other person or entity except as provided herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u> </u><u>Acknowledgement of Counsel</u>. Each Party acknowledges that it was represented by counsel. Accordingly, any rule of law or any legal decision that would provide any Party with a defense to the enforcement of the terms of this Settlement Agreement against such Party based upon lack of legal counsel shall have no application and is expressly waived. The provisions of this Settlement Agreement shall be interpreted in a reasonable manner to affect the intent of the Parties hereto. No Party shall have any term or provision construed against such party solely by reason of such Party having drafted the same.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Headings and Captions</u>**.** The captions in this Settlement Agreement are intended for convenience and reference only and do not constitute and shall not be interpreted as part of this Settlement Agreement and shall not affect the meaning or interpretation of this Settlement Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Counterparts</u>. This Settlement Agreement may be executed via facsimile or email and in any number of counterparts, all of which taken together shall constitute one agreement. For purposes of enforceability, a copy of this fully executed Settlement Agreement shall have the same authority as an executed original document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;&nbsp;&nbsp;&nbsp; <u>Entire Agreement; Modification</u>. This Settlement Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof, and supersedes all prior agreements and understandings, if any, relating to the subject matter hereof. Any promises, representations, warranties or guarantees not herein contained and hereinafter made shall have no force and effect unless in writing signed by each Party. No provision of this Settlement Agreement may be changed, modified, amended, restated, waived, supplemented, discharged, canceled or terminated orally or by any course of dealing or in any other manner other than by an agreement in writing signed by each Party.

[*Remainder of page intentionally left blank; signature page follows.*]

------

IN WITNESS WHEREOF, intending to be bound, each of the undersigned has executed this Settlement Agreement as of the date indicated.

---

| | |
|:---|:---|
| **WOLFSPEED, INC.** | **WOLFSPEED, INC.** |
| By: | /s/ Melissa Garret |
| Name: | Melissa Garrett |
| Its: | SVP, General Counsel - Legal |
| Date: | February 7, 2025 |

---

---

| | |
|:---|:---|
| CHARLES & COLVARD, LTD. | CHARLES & COLVARD, LTD. |
| By:  | /s/ Don O'Connell |
| Name: | Don O'Connell |
| Its: | President & CEO |
| Date: | February 7, 2025 |

---

------

## Exhibit 31.1

------

#### Exhibit 31.1

#### CERTIFICATION PURSUANT TO SECURITIES AND EXCHANGE ACT OF 1934

#### RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302

#### OF THE SARBANES-OXLEY ACT OF 2002

I, Don O'Connell, certify that:

<br> 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 of Charles & Colvard, Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

<br> (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

<br> (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
|  | By: | /s/ Don O'Connell |
| August 4, 2025 |  | Don O'Connell |
|  |  | President and Chief Executive Officer |

---

------

## Exhibit 31.2

------

#### Exhibit 31.2

#### CERTIFICATION PURSUANT TO SECURITIES AND EXCHANGE ACT OF 1934

#### RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302

#### OF THE SARBANES-OXLEY ACT OF 2002

I, Clint J. Pete, certify that:

<br> 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 of Charles & Colvard, Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

<br> (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

<br> (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
|  | By: | /s/ Clint J. Pete |
| August 4, 2025 |  | Clint J. Pete |
|  |  | Chief Financial Officer |

---

------

## Exhibit 32.1

------

#### Exhibit 32.1

#### CERTIFICATION PURSUANT TO

#### 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

#### SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the "Company") on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Don O'Connell, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

<br> (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

<br> (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | <u>/s/ Don O'Connell</u> |
|  | Don O'Connell |
|  | President and Chief Executive Officer |
|  | August 4, 2025 |

---

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed "filed" by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

------

## Exhibit 32.2

------

#### Exhibit 32.2

#### CERTIFICATION PURSUANT TO

#### 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

#### SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the "Company") on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Clint J. Pete, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

<br> (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

<br> (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | <u>/s/ Clint J. Pete</u> |
|  | Clint J. Pete |
|  | Chief Financial Officer |
|  | August 4, 2025 |

---

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed "filed" by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

------